Today’s stock upgrades and downgrades. Wall Street’s top analysts’ price targets for stocks. Daily stock analyst price targets.
3-13-2026
Scotiabank maintains CubeSmart CUBE at Sector Perform and raises the price target from $39 to $42
B. Riley Securities maintains ChargePoint Hldgs at Neutral and lowers the price target from $11 to $6
Lake Street maintains American Public Education APEI at Buy and raises the price target from $47 to $56
Goldman Sachs maintains LandBridge at Buy and raises the price target from $69 to $84
Goldman Sachs maintains EverCommerce EVCM at Sell and lowers the price target from $9 to $8
Goldman Sachs maintains SentinelOne at Neutral and lowers the price target from $16.5 to $14.5
Piper Sandler maintains Allogene Therapeutics ALLO at Overweight and raises the price target from $7 to $8
JP Morgan maintains Morgan Stanley Direct at Neutral and lowers the price target from $16.5 to $14
Wells Fargo maintains Williams Companies WMB at Overweight and raises the price target from $80 to $89
Morgan Stanley maintains ServiceTitan at Overweight and lowers the price target from $131 to $118
Wells Fargo maintains Hess Midstream HESM at Equal-Weight and raises the price target from $39 to $40
Morgan Stanley maintains Dollar General at Equal-Weight and lowers the price target from $160 to $150
Wells Fargo maintains Targa Resources TRGP at Overweight and raises the price target from $248 to $264
Wells Fargo maintains Plains GP Holdings at Equal-Weight and raises the price target from $21 to $22
Wells Fargo maintains Plains All American PAA at Equal-Weight and raises the price target from $21 to $22
Wells Fargo maintains ONEOK at Equal-Weight and raises the price target from $79 to $81
Wells Fargo maintains Enterprise Prods Partners EPD at Equal-Weight and raises the price target from $38 to $40
Wells Fargo maintains Energy Transfer at Overweight and raises the price target from $23 to $25
Stifel maintains Oruka Therapeutics ORKA at Buy and raises the price target from $47 to $72
Wells Fargo maintains DT Midstream at Overweight and raises the price target from $150 to $165
Stifel maintains Kinder Morgan KMI at Hold and raises the price target from $30 to $33
Wells Fargo maintains Archrock at Overweight and raises the price target from $39 to $40
Wells Fargo maintains Western Midstream WES at Equal-Weight and raises the price target from $39 to $41
Wells Fargo maintains Sunoco at Overweight and raises the price target from $67 to $71
Wells Fargo maintains Antero Midstream AM at Equal-Weight and raises the price target from $21 to $23
RBC Capital maintains Ollie’s Bargain Outlet at Outperform and raises the price target from $147 to $155
RBC Capital maintains Ducommun DCO at Outperform and raises the price target from $142 to $150
B. Riley Securities upgrades Hallador Energy from Neutral to Buy and raises the price target from $23 to $27
TD Cowen maintains Silvaco Group SVCO at Buy and lowers the price target from $8 to $6
Mizuho maintains Sarepta Therapeutics at Outperform and raises the price target from $26 to $31
TD Cowen maintains ServiceTitan TTAN at Buy and raises the price target from $130 to $135
TD Cowen maintains PagerDuty at Buy and lowers the price target from $20 to $10
TD Cowen maintains Cognizant Tech Solns CTSH at Hold and lowers the price target from $85 to $71
Barclays downgrades Adobe from Overweight to Equal-Weight and lowers the price target from $335 to $275
Mizuho maintains Erasca ERAS at Outperform and raises the price target from $16 to $19
Cantor Fitzgerald maintains Korro Bio at Overweight and raises the price target from $21 to $22
Cantor Fitzgerald maintains Health Catalyst HCAT at Neutral and lowers the price target from $4 to $3
Cantor Fitzgerald reiterates Rocket Lab at Overweight and maintains the price target at $85
Guggenheim reiterates Oracle ORCL at Buy and maintains the price target at $400
Guggenheim maintains Relay Therapeutics at Buy and raises the price target from $15 to $22
Guggenheim maintains Adicet Bio ACET at Buy and lowers the price target from $128 to $100
Citigroup upgrades Knight-Swift from Neutral to Buy and maintains the price target at $64
Benchmark maintains Gambling .com GAMB at Buy and lowers the price target from $7 to $6
JP Morgan upgrades Linde LIN from Neutral to Overweight and raises the price target from $455 to $525
Benchmark maintains Vivid Seats at Buy and lowers the price target from $18 to $10
Wedbush reiterates Unity Software U at Outperform and maintains the price target at $30
Wedbush reiterates Voyager Technologies at Outperform and maintains the price target at $46
Wedbush reiterates SentinelOne S at Outperform and maintains the price target at $20
JP Morgan upgrades Alcoa from Underweight to Neutral and raises the price target from $50 to $68
Wedbush maintains Rubrik RBRK at Outperform and lowers the price target from $120 to $90
Wells Fargo upgrades Celanese from Equal-Weight to Overweight and raises the price target from $55 to $70
Wells Fargo maintains Air Products APD at Equal-Weight and raises the price target from $270 to $325
Wells Fargo upgrades Ollie’s Bargain Outlet from Equal-Weight to Overweight and raises the price target from $120 to $130
Mizuho maintains Circle Internet Group at Neutral and raises the price target from $100 to $120
Guggenheim maintains Dollar General DG at Buy and lowers the price target from $165 to $160
Needham maintains RingCentral at Buy and raises the price target from $36 to $55
BTIG maintains FTAI Aviation FTAI at Buy and raises the price target from $335 to $340
BTIG reiterates ServiceTitan at Buy and maintains the price target at $105
Needham maintains SentinelOne S at Buy and lowers the price target from $21 to $18
BTIG reiterates Amplitude at Buy and maintains the price target at $10
Needham reiterates Oncology Institute TOI at Buy and maintains the price target at $5
Needham reiterates Zoom Communications at Buy and maintains the price target at $100
HC Wainwright & Co. maintains Erasca ERAS at Buy and raises the price target from $15 to $20
Morgan Stanley downgrades Nerdwallet NRDS from Equal-Weight to Underweight and lowers the price target from $14 to $9
Morgan Stanley downgrades KinderCare Learning KLC from Equal-Weight to Underweight and lowers the price target from $6 to $2.5
Citizens maintains Esperion Therapeutics at Market Outperform and raises the price target from $4 to $5
Deutsche Bank upgrades Qiagen QGEN from Hold to Buy and maintains the price target at $54
Itau BBA upgrades BBB Foods TBBB from Market Perform to Outperform and announces a price target of $42
Baird downgrades Immutep IMMP from Outperform to Neutral and lowers the price target from $7 to $1
Baird downgrades KinderCare Learning KLC from Outperform to Neutral and lowers the price target from $8 to $1.5
Baird initiates coverage on H2O America at Outperform rating and announces a price target of $67
Piper Sandler maintains Adobe ADBE at Neutral and lowers the price target from $330 to $280
Piper Sandler reiterates ServiceTitan at Overweight and maintains the price target at $120
3-12-2026
UBS maintains Core Natural Resources CNR at Buy and raises the price target from $105 to $109
UBS maintains Alcoa at Neutral and raises the price target from $48 to $70
JP Morgan maintains Consolidated Edison ED at Underweight and raises the price target from $107 to $113
JP Morgan maintains American Electric Power at Neutral and raises the price target from $125 to $139
JP Morgan maintains Jabil JBL at Overweight and raises the price target from $270 to $300
JP Morgan maintains Neurocrine Biosciences at Overweight and raises the price target from $176 to $177
Jefferies maintains American Airlines Group AAL at Hold and lowers the price target from $15 to $12
Morgan Stanley maintains AMETEK at Equal-Weight and raises the price target from $215 to $235
Citigroup maintains Oracle ORCL at Buy and raises the price target from $310 to $320
Goldman Sachs maintains Valero Energy at Buy and raises the price target from $203 to $237
Goldman Sachs maintains Suncor Energy SU at Buy and raises the price target from $55 to $62
Goldman Sachs maintains Piper Sandler at Buy and lowers the price target from $461 to $392
Goldman Sachs maintains Phillips 66 PSX at Neutral and raises the price target from $168 to $186
Goldman Sachs maintains Perella Weinberg at Sell and lowers the price target from $21.5 to $18.5
Goldman Sachs maintains PBF Energy PBF at Neutral and raises the price target from $33 to $41
Goldman Sachs maintains Par Pacific Hldgs PARR at Neutral and raises the price target from $44 to $53
Goldman Sachs maintains Moelis at Neutral and lowers the price target from $80 to $70
Goldman Sachs maintains Marathon Petroleum MPC at Buy and raises the price target from $211 to $239
Goldman Sachs maintains Lazard at Sell and lowers the price target from $53 to $46
Goldman Sachs maintains Jefferies Financial JEF at Buy and lowers the price target from $61 to $54
Goldman Sachs maintains Houlihan Lokey at Buy and lowers the price target from $243 to $210
Goldman Sachs maintains Groupon GRPN at Sell and lowers the price target from $17 to $10
Goldman Sachs maintains Evercore at Buy and lowers the price target from $447 to $383
Goldman Sachs maintains CVR Energy CVI at Sell and raises the price target from $22 to $25
Goldman Sachs maintains Cenovus Energy at Buy and raises the price target from $22 to $29
Goldman Sachs maintains Canadian Natural Res CNQ at Buy and raises the price target from $37 to $49
Goldman Sachs maintains Calumet at Buy and raises the price target from $24 to $34
Citigroup maintains Bumble BMBL at Neutral and raises the price target from $3.8 to $3.9
Citigroup maintains Global Business Travel at Buy and lowers the price target from $11 to $9
RBC Capital maintains Netskope NTSK at Outperform and lowers the price target from $19 to $14
RBC Capital upgrades Kinross Gold from Sector Perform to Outperform and raises the price target from $36 to $45
Craig-Hallum maintains Acacia Research ACTG at Buy and raises the price target from $5 to $6
Citigroup maintains Westlake at Buy and raises the price target from $124 to $130
Citigroup maintains Olin OLN at Neutral and raises the price target from $21 to $26
Citigroup maintains Eastman Chemical at Buy and raises the price target from $78 to $84
Citigroup maintains Celanese CE at Buy and raises the price target from $75 to $81
B of A Securities maintains Bumble at Underperform and lowers the price target from $3.5 to $3.3
DA Davidson maintains Natures Sunshine Products NATR at Buy and raises the price target from $23 to $33
Wedbush maintains AnaptysBio at Outperform and raises the price target from $60 to $75
Wedbush maintains Solid Biosciences SLDB at Outperform and raises the price target from $14 to $17
Wedbush maintains Dianthus Therapeutics at Outperform and raises the price target from $80 to $103
Cantor Fitzgerald assumes Anteris Technologies Glb AVR at Overweight rating and announces a price target of $15
B of A Securities maintains Corning GLW at Buy and raises the price target from $120 to $144
Citigroup downgrades Generac Holdings from Buy to Neutral and raises the price target from $207 to $237
CIBC upgrades SSR Mining SSRM from Neutral to Outperformer and announces a price target of $48
Jefferies upgrades Petco Health and Wellness WOOF from Hold to Buy and raises the price target from $4.05 to $5
Jefferies upgrades Nutrien from Hold to Buy and raises the price target from $74 to $96
Benchmark maintains TAT Technologies TATT at Buy and raises the price target from $58 to $66
Bernstein upgrades CVS Health from Market Perform to Outperform and raises the price target from $91 to $94
UBS upgrades Aptiv from Neutral to Buy and raises the price target from $89 to $97
Evercore ISI Group maintains United Airlines Holdings UAL at Outperform and lowers the price target from $140 to $125
Citigroup upgrades LyondellBasell Industries LYB from Neutral to Buy and raises the price target from $49 to $76
Citigroup upgrades Dow DOW from Neutral to Buy and raises the price target from $28 to $40
Bernstein maintains SLB at Outperform and raises the price target from $52.3 to $56.1
Barclays maintains UniFirst UNF at Equal-Weight and raises the price target from $250 to $280
Evercore ISI Group maintains JetBlue Airways at In-Line and lowers the price target from $6 to $5
Keybanc maintains Netskope NTSK at Overweight and lowers the price target from $17 to $15
Barclays maintains Atlas Energy Solutions at Underweight and raises the price target from $8 to $11
Evercore ISI Group maintains Delta Air Lines DAL at Outperform and lowers the price target from $85 to $80
Wells Fargo maintains Bumble at Equal-Weight and lowers the price target from $5.5 to $5
Wells Fargo maintains Century Aluminum CENX at Overweight and raises the price target from $61 to $69
Wells Fargo maintains Merck & Co at Overweight and raises the price target from $135 to $150
TD Cowen initiates coverage on Ciena CIEN at Buy rating and announces a price target of $425
HSBC upgrades Pampa Energia from Hold to Buy and raises the price target from $88 to $97
Wells Fargo maintains Kraft Heinz KHC at Equal-Weight and lowers the price target from $25 to $23
Wells Fargo downgrades Conagra Brands from Equal-Weight to Underweight and lowers the price target from $20 to $15
Evercore ISI Group maintains American Airlines Group AAL at In-Line and lowers the price target from $17 to $14
Citizens maintains SuRo Capital at Market Outperform and raises the price target from $11 to $13
Mizuho maintains Tenet Healthcare THC at Outperform and raises the price target from $235 to $265
Wedbush maintains Opus Genetics at Outperform and raises the price target from $8 to $10
Mizuho maintains PENN Entertainment PENN at Outperform and raises the price target from $19 to $22
Telsey Advisory Group maintains FIGS at Market Perform and raises the price target from $15 to $17
Mizuho maintains Molina Healthcare MOH at Outperform and lowers the price target from $220 to $180
Stephens & Co. reiterates Darden Restaurants at Equal-Weight and maintains the price target at $205
BTIG maintains AeroVironment AVAV at Buy and lowers the price target from $415 to $330
Baird maintains Netskope at Outperform and lowers the price target from $27 to $20
Barrington Research maintains CuriosityStream CURI at Outperform and lowers the price target from $6 to $5.5
Morgan Stanley maintains Vail Resorts at Equal-Weight and lowers the price target from $151 to $147
HC Wainwright & Co. maintains Vista Gold VGZ at Buy and lowers the price target from $5 to $4.5
Morgan Stanley maintains Honeywell Intl at Equal-Weight and raises the price target from $235 to $245
Morgan Stanley maintains Netskope NTSK at Overweight and lowers the price target from $27 to $18
Morgan Stanley maintains Bumble at Equal-Weight and raises the price target from $3.5 to $4
Morgan Stanley maintains Caesars Entertainment CZR at Equal-Weight and raises the price target from $25 to $32
HC Wainwright & Co. maintains Ur-Energy at Buy and lowers the price target from $2.6 to $2.3
Morgan Stanley maintains UiPath PATH at Equal-Weight and lowers the price target from $19 to $17
HC Wainwright & Co. maintains Minerva Neurosciences at Neutral and raises the price target from $4 to $7
BTIG maintains Lululemon Athletica LULU at Buy and lowers the price target from $303 to $250
Stifel maintains The Campbell’s at Hold and lowers the price target from $30 to $25
BTIG maintains Netskope NTSK at Buy and lowers the price target from $22 to $17
BTIG maintains Ginkgo Bioworks Holdings at Sell and lowers the price target from $9 to $5
Evercore ISI Group initiates coverage on vTv Therapeutics VTVT at Outperform rating and announces a price target of $44
BTIG maintains Exodus Movement at Buy and lowers the price target from $30 to $20
Keybanc initiates coverage on Life Time Group Holdings LTH at Overweight rating and announces a price target of $40
BTIG assumes Innate Pharma at Buy rating and announces a price target of $8
Keybanc initiates coverage on Planet Fitness PLNT at Overweight rating and announces a price target of $100
BTIG maintains ServiceTitan at Buy and lowers the price target from $130 to $105
B of A Securities initiates coverage on Enovix ENVX at Neutral rating and announces a price target of $6
BTIG assumes ImmunityBio at Buy rating and announces a price target of $13
Baird initiates coverage on Jabil JBL at Outperform rating and announces a price target of $275
Piper Sandler upgrades Occidental Petroleum OXY from Neutral to Overweight and raises the price target from $54 to $66
Piper Sandler upgrades Murphy Oil MUR from Neutral to Overweight and raises the price target from $33 to $41
Keefe, Bruyette & Woods downgrades Wealthfront from Outperform to Market Perform and lowers the price target from $13.5 to $9.5
Goldman Sachs maintains Live Nation Entertainment LYV at Buy and raises the price target from $175 to $190
Freedom Capital Markets initiates coverage on Rush Street Interactive at Buy rating and announces a price target of $25
3-11-2026
DA Davidson maintains Trex Co at Buy and raises the price target from $50 to $51
Scotiabank maintains Lineage LINE at Sector Perform and raises the price target from $39 to $42
Roth Capital maintains Core Molding Technologies at Buy and raises the price target from $22 to $24
B. Riley Securities reiterates Stagwell STGW at Buy and raises the price target from $7 to $8
BTIG maintains SuRo Capital at Buy and raises the price target from $10.5 to $12.5
Morgan Stanley maintains Repay Holdings RPAY at Equal-Weight and lowers the price target from $4 to $3.5
Goldman Sachs maintains Permian Resources at Buy and raises the price target from $17 to $22
Goldman Sachs maintains Ovintiv OVV at Buy and raises the price target from $49 to $62
Goldman Sachs maintains Occidental Petroleum at Sell and raises the price target from $41 to $54
Goldman Sachs maintains Murphy Oil MUR at Neutral and raises the price target from $29 to $33
Goldman Sachs maintains Kohl’s at Sell and lowers the price target from $15 to $13
Goldman Sachs maintains Diamondback Energy FANG at Buy and raises the price target from $187 to $212
Goldman Sachs maintains Casey’s General Stores at Neutral and raises the price target from $530 to $605
Goldman Sachs maintains Carnival CCL at Buy and lowers the price target from $34 to $30
Goldman Sachs maintains APA at Sell and raises the price target from $23 to $29
Citigroup maintains Icon at Neutral and lowers the price target from $200 to $120
Evercore ISI Group maintains Casey’s General Stores CASY at Outperform and raises the price target from $750 to $765
Citigroup maintains BioNTech at Buy and lowers the price target from $145 to $130
Stifel maintains Oracle ORCL at Buy and lowers the price target from $275 to $220
Citigroup maintains Alpha Tau Medical at Buy and raises the price target from $7 to $9
Citigroup maintains Johnson & Johnson JNJ at Buy and raises the price target from $250 to $274
Citigroup maintains Insulet at Buy and lowers the price target from $345 to $338
Citigroup maintains Haemonetics HAE at Neutral and lowers the price target from $75 to $70
Citigroup maintains GE HealthCare Techs at Neutral and lowers the price target from $88 to $84
Citigroup maintains Establishment Labs Hldgs ESTA at Neutral and lowers the price target from $81 to $74
Stifel reiterates Ameresco AMEC at Buy and raises the price target from $37 to $38
Citigroup maintains DexCom at Buy and raises the price target from $77 to $84
Citigroup maintains Boston Scientific BSX at Buy and lowers the price target from $102 to $94
Stifel maintains AeroVironment at Buy and lowers the price target from $389 to $315
Citigroup maintains Abbott Laboratories ABT at Buy and lowers the price target from $140 to $136
Wells Fargo maintains Blend Labs at Overweight and lowers the price target from $5 to $4
Truist Securities maintains Vertex Pharmaceuticals VRTX at Buy and raises the price target from $490 to $525
Wells Fargo maintains Rapport Therapeutics at Overweight and raises the price target from $43 to $46
Wells Fargo maintains United Natural Foods UNFI at Equal-Weight and raises the price target from $35 to $40
Barclays maintains Oracle at Overweight and raises the price target from $230 to $240
Barclays maintains Hims & Hers Health HIMS at Overweight and raises the price target from $25 to $29
Keefe, Bruyette & Woods maintains Cipher Digital CIFR at Outperform and lowers the price target from $22 to $20
TD Cowen maintains TKO Group Holdings at Buy and raises the price target from $245 to $250
TD Cowen maintains PROG Holdings PRG at Buy and raises the price target from $42 to $43
TD Cowen maintains Biohaven at Buy and raises the price target from $15 to $30
Barclays initiates coverage on Nova NVMI at Overweight rating and announces a price target of $465
TD Cowen maintains BioNTech at Hold and lowers the price target from $116 to $94
RBC Capital reiterates Oracle ORCL at Sector Perform and maintains the price target at $160
RBC Capital maintains Legend Biotech at Outperform and lowers the price target from $66 to $62
BMO Capital maintains BioNTech BNTX at Outperform and lowers the price target from $143 to $128
JP Morgan downgrades Day One Biopharmaceutical from Overweight to Neutral and lowers the price target from $27 to $21.5
BMO Capital maintains United Natural Foods UNFI at Outperform and raises the price target from $48 to $52
Barclays upgrades Willis Towers Watson from Underweight to Equal-Weight and raises the price target from $318 to $341
BMO Capital maintains Matador Resources MTDR at Outperform and raises the price target from $60 to $65
RBC Capital maintains Howmet Aerospace at Outperform and raises the price target from $275 to $300
RBC Capital maintains Hinge Health HNGE at Outperform and raises the price target from $50 to $55
Barclays upgrades Arthur J. Gallagher AJG from Underweight to Overweight and raises the price target from $247 to $262
BMO Capital maintains Bunge Global at Outperform and raises the price target from $130 to $135
RBC Capital initiates coverage on Alliant Energy LNT at Outperform rating and announces a price target of $82
JP Morgan upgrades Oracle from Neutral to Overweight and lowers the price target from $230 to $210
Citigroup upgrades Intuitive Surgical ISRG from Neutral to Buy and maintains the price target at $590
Truist Securities maintains Thor Industries at Hold and lowers the price target from $112 to $109
Truist Securities maintains Septerna SEPN at Buy and raises the price target from $34 to $35
Cantor Fitzgerald maintains Domo at Overweight and lowers the price target from $13 to $8
Telsey Advisory Group maintains Kohl’s KSS at Market Perform and lowers the price target from $23 to $17
Cantor Fitzgerald reiterates Oracle at Overweight and maintains the price target at $229
DA Davidson maintains Oracle ORCL at Buy and raises the price target from $180 to $200
Mizuho maintains Tango Therapeutics at Outperform and raises the price target from $19 to $20
Wells Fargo initiates coverage on Polaris PII at Equal-Weight rating and announces a price target of $52
Wells Fargo initiates coverage on Planet Fitness at Overweight rating and announces a price target of $90
Wells Fargo initiates coverage on Mattel MAT at Overweight rating and announces a price target of $19
Wells Fargo initiates coverage on Hasbro at Equal-Weight rating and announces a price target of $98
Wells Fargo initiates coverage on Harley-Davidson HOG at Underweight rating and announces a price target of $15
Mizuho maintains Safehold at Neutral and raises the price target from $15 to $16
Clear Street maintains MoonLake MLTX at Buy and raises the price target from $45 to $70
Guggenheim maintains Jade Biosciences at Buy and raises the price target from $17 to $23
Guggenheim maintains Accenture ACN at Buy and lowers the price target from $305 to $275
Bernstein upgrades JM Smucker SJM from Market Perform to Outperform and raises the price target from $121 to $145
B of A Securities maintains BioMarin Pharmaceutical at Buy and lowers the price target from $97 to $85
HC Wainwright & Co. maintains Uranium Energy UEC at Buy and raises the price target from $26.5 to $26.75
BTIG upgrades Apyx Medical from Neutral to Buy and announces a price target of $6
Ascendiant Capital maintains Genasys GNSS at Buy and raises the price target from $5.25 to $5.5
Mizuho upgrades uniQure QURE from Neutral to Outperform and raises the price target from $12 to $35
BTIG maintains Shoulder Innovations at Buy and raises the price target from $23 to $24
Goldman Sachs maintains Lululemon Athletica LULU at Neutral and lowers the price target from $200 to $184
Piper Sandler maintains Oracle at Overweight and lowers the price target from $240 to $210
3-10-2026
UBS maintains Sunrun at Buy and lowers the price target from $26 to $23
UBS maintains Academy Sports ASO at Neutral and raises the price target from $54 to $60
UBS maintains Signet Jewelers at Buy and raises the price target from $115 to $118
UBS maintains Jabil JBL at Neutral and raises the price target from $244 to $254
JP Morgan maintains XPO at Overweight and raises the price target from $189 to $201
JP Morgan maintains Old Dominion Freight Line ODFL at Neutral and raises the price target from $168 to $182
JP Morgan maintains MPLX at Neutral and raises the price target from $58 to $60
JP Morgan maintains Morgan Stanley at Neutral and raises the price target from $173 to $179
JP Morgan maintains Medline MDLN at Overweight and raises the price target from $50 to $53
JP Morgan maintains Goldman Sachs Group at Neutral and raises the price target from $815 to $826
JP Morgan maintains FedEx FDX at Neutral and raises the price target from $294 to $424
JP Morgan maintains Enterprise Prods Partners at Neutral and raises the price target from $35 to $39
JP Morgan maintains BridgeBio Pharma BBIO at Overweight and raises the price target from $89 to $94
JP Morgan maintains Embraer at Overweight and raises the price target from $80 to $84
B of A Securities maintains Thomson Reuters TRI at Neutral and raises the price target from $100 to $115
B of A Securities maintains HUTCHMED at Buy and lowers the price target from $21 to $20
Morgan Stanley maintains Energy Transfer ET at Equal-Weight and raises the price target from $19 to $21
Morgan Stanley maintains Marriott International at Overweight and raises the price target from $328 to $331
Morgan Stanley maintains Global Business Travel GBTG at Equal-Weight and lowers the price target from $8 to $7
Morgan Stanley maintains GitLab at Equal-Weight and lowers the price target from $38 to $29
Morgan Stanley maintains BETA Technologies BETA at Overweight and lowers the price target from $34 to $33
Rothschild & Co upgrades Intuit from Neutral to Buy and raises the price target from $670 to $700
Jefferies maintains Dow DOW at Hold and raises the price target from $28 to $39
Jefferies maintains LyondellBasell Industries at Hold and raises the price target from $51 to $70
Canaccord Genuity maintains Ulta Beauty ULTA at Buy and raises the price target from $674 to $799
Canaccord Genuity maintains Natures Sunshine Products at Buy and raises the price target from $22 to $29
Morgan Stanley maintains Hewlett Packard HPE at Equal-Weight and raises the price target from $23 to $25
Morgan Stanley maintains Vertex Pharmaceuticals at Overweight and raises the price target from $570 to $596
Canaccord Genuity maintains Beachbody Co BODI at Buy and raises the price target from $9 to $12
Canaccord Genuity maintains WAVE Life Sciences at Buy and raises the price target from $43 to $52
Canaccord Genuity maintains Fluent FLNT at Hold and raises the price target from $2.5 to $3.5
B of A Securities maintains Vertex Pharmaceuticals at Buy and raises the price target from $571 to $598
B of A Securities maintains Paramount Skydance PSKY at Underperform and lowers the price target from $13 to $11
B of A Securities maintains Hewlett Packard at Buy and raises the price target from $29 to $32
DA Davidson maintains Target TGT at Buy and raises the price target from $120 to $140
Citigroup maintains Sarepta Therapeutics at Sell and raises the price target from $8 to $9
Citigroup maintains Bioage Labs BIOA at Buy and raises the price target from $15 to $52
Oppenheimer maintains Vertex Pharmaceuticals at Outperform and raises the price target from $540 to $600
Scotiabank maintains Gaming and Leisure Props GLPI at Sector Perform and raises the price target from $48 to $50
Oppenheimer reiterates Semtech at Outperform and raises the price target from $81 to $100
Oppenheimer maintains Rentokil Initial RTO at Outperform and raises the price target from $30 to $35
Barclays maintains Macrogenics at Overweight and raises the price target from $3 to $4
Barclays maintains Lam Research LRCX at Equal-Weight and raises the price target from $250 to $255
Oppenheimer maintains Corbus Pharmaceuticals at Outperform and raises the price target from $53 to $57
Barclays maintains Five Below FIVE at Equal-Weight and raises the price target from $193 to $211
Oppenheimer reiterates AutoZone at Outperform and raises the price target from $4150 to $4300
Jefferies initiates coverage on Amgen AMGN at Hold rating and announces a price target of $350
Jefferies initiates coverage on Gilead Sciences at Buy rating and announces a price target of $180
Compass Point initiates coverage on Rocket Companies RKT at Buy rating and announces a price target of $21
RBC Capital maintains Kinetik Holdings at Outperform and raises the price target from $46 to $49
RBC Capital maintains Design Therapeutics DSGN at Outperform and raises the price target from $13 to $14
Citigroup upgrades Hims & Hers Health from Sell to Neutral and raises the price target from $13.25 to $24
Keefe, Bruyette & Woods maintains Nayax NYAX at Market Perform and raises the price target from $52 to $60
Benchmark maintains Repay Holdings at Buy and lowers the price target from $8 to $6
Deutsche Bank maintains Xenon Pharmaceuticals at Buy and raises the price target from $56 to $90
B of A Securities maintains Progressive PGR at Buy and lowers the price target from $315 to $308
B of A Securities upgrades Hims & Hers Health HIMS from Underperform to Neutral and raises the price target from $12.5 to $23
B of A Securities upgrades TELUS from Neutral to Buy and raises the price target from $14.5 to $16
HC Wainwright & Co. maintains Climb Bio CLYM at Buy and raises the price target from $11 to $15
B of A Securities upgrades SolarEdge Technologies SEDG from Underperform to Neutral and raises the price target from $17 to $40
Baird maintains Oracle at Outperform and lowers the price target from $300 to $200
Baird maintains RideNow Group RDNW at Neutral and raises the price target from $5 to $7
Needham maintains Celcuity CELC at Buy and raises the price target from $95 to $122
B. Riley Securities initiates coverage on Strive at Buy rating and announces a price target of $12
Ascendiant Capital maintains LiqTech International LIQT at Buy and raises the price target from $4.2 to $4.3
B. Riley Securities initiates coverage on Strategy at Buy rating and announces a price target of $175
Mizuho initiates coverage on Maze Therapeutics MAZE at Outperform rating and announces a price target of $97
Morgan Stanley upgrades CrowdStrike Holdings from Equal-Weight to Overweight and raises the price target from $487 to $510
Clear Street maintains Dianthus Therapeutics DNTH at Buy and raises the price target from $100 to $130
3-9-2026
TD Cowen maintains Southwest Airlines at Buy and lowers the price target from $66 to $55
TD Cowen maintains Delta Air Lines DAL at Buy and lowers the price target from $82 to $71
TD Cowen maintains Alaska Air Group at Buy and lowers the price target from $63 to $54
TD Cowen maintains American Airlines Group AAL at Buy and lowers the price target from $17 to $13
TD Cowen upgrades IQVIA Holdings from Hold to Buy and raises the price target from $174 to $213
Baird maintains Xenon Pharmaceuticals XENE at Outperform and raises the price target from $63 to $97
Cantor Fitzgerald maintains Rubrik at Overweight and lowers the price target from $105 to $85
JP Morgan maintains Timken TKR at Neutral and raises the price target from $90 to $100
JP Morgan maintains Mirion Technologies at Overweight and lowers the price target from $33 to $30
JP Morgan maintains Carlisle Companies CSL at Overweight and raises the price target from $400 to $420
Evercore ISI Group maintains Zymeworks at Outperform and raises the price target from $33 to $48
Evercore ISI Group maintains EVgo EVGO at Outperform and lowers the price target from $4 to $3.5
Evercore ISI Group maintains Atea Pharmaceuticals at Outperform and raises the price target from $6 to $10
DA Davidson maintains Toro TTC at Buy and raises the price target from $97 to $117
DA Davidson maintains Miller Industries at Buy and raises the price target from $52 to $53
DA Davidson maintains Mayville Engineering MEC at Buy and raises the price target from $21 to $23
Tigress Financial maintains Medline at Buy and raises the price target from $55 to $60
UBS maintains Macy’s M at Sell and raises the price target from $8 to $9
Citigroup maintains EyePoint at Buy and raises the price target from $31 to $35
Citigroup maintains Kroger KR at Neutral and raises the price target from $68 to $71
Citigroup maintains Caterpillar at Buy and raises the price target from $760 to $785
Deutsche Bank maintains Oracle ORCL at Buy and lowers the price target from $375 to $300
Citigroup maintains Uniti Group at Neutral and raises the price target from $8.8 to $9
Citigroup maintains ArcBest ARCB at Buy and raises the price target from $105 to $107
B. Riley Securities maintains Amprius Technologies at Buy and raises the price target from $16 to $22
Scotiabank maintains Oracle ORCL at Sector Outperform and lowers the price target from $220 to $215
Wells Fargo maintains Adobe at Overweight and lowers the price target from $420 to $405
Barclays maintains South Bow SOBO at Equal-Weight and raises the price target from $27 to $33
Barclays maintains Oracle at Overweight and lowers the price target from $310 to $230
Barclays maintains H2O America HTO at Overweight and raises the price target from $61 to $63
Barclays maintains Evergy at Overweight and raises the price target from $82 to $89
Morgan Stanley maintains Vulcan Materials VMC at Equal-Weight and raises the price target from $321 to $322
RBC Capital upgrades uniQure QURE from Sector Perform to Outperform and raises the price target from $11 to $35
RBC Capital upgrades LyondellBasell Industries LYB from Sector Perform to Outperform and raises the price target from $51 to $82
RBC Capital upgrades Dow from Sector Perform to Outperform and raises the price target from $29 to $40
UBS initiates coverage on SOLV Energy MWH at Buy rating and announces a price target of $42
UBS upgrades PG&E from Neutral to Buy and raises the price target from $20 to $23
Citigroup upgrades Terex TEX from Neutral to Buy and raises the price target from $73 to $75
JP Morgan upgrades Cognex from Underweight to Neutral and announces a price target of $55
Susquehanna maintains Semtech SMTC at Positive and raises the price target from $90 to $100
Stifel maintains Tango Therapeutics at Buy and raises the price target from $15 to $24
Canaccord Genuity maintains Bridger Aerospace Group BAER at Buy and lowers the price target from $5.25 to $5
Stifel maintains TransMedics Group at Hold and raises the price target from $115 to $130
Stifel maintains RxSight RXST at Hold and lowers the price target from $10 to $9
Wells Fargo upgrades uniQure QURE from Equal-Weight to Overweight and raises the price target from $15 to $60
Rothschild & Co upgrades GE Vernova GEV from Sell to Buy and raises the price target from $560 to $1100
Stifel maintains Alcon at Hold and raises the price target from $80 to $82
Truist Securities maintains AnaptysBio ANAB at Hold and raises the price target from $36 to $50
Wolfe Research initiates coverage on Wingstop at Outperform rating and announces a price target of $320
Mizuho initiates coverage on Arko Petroleum at Neutral rating and announces a price target of $20
Morgan Stanley initiates coverage on AGI AGBK at Overweight rating and announces a price target of $21
Baird initiates coverage on SOLV Energy at Outperform rating and announces a price target of $36
BTIG reiterates Maze Therapeutics MAZE at Buy and maintains the price target at $46
HC Wainwright & Co. maintains Fury Gold Mines at Buy and raises the price target from $1.4 to $2
3-6-2026
HC Wainwright & Co. maintains Tango Therapeutics TNGX at Buy and raises the price target from $13 to $27
HC Wainwright & Co. maintains Zymeworks at Buy and raises the price target from $32 to $46
Benchmark upgrades Marvell Technology MRVL from Hold to Buy and announces a price target of $130
B of A Securities downgrades Tanger from Buy to Neutral and maintains the price target at $39
BTIG maintains Samsara IOT at Buy and lowers the price target from $55 to $45
B of A Securities upgrades Ciena CIEN from Neutral to Buy and raises the price target from $260 to $355
B of A Securities upgrades Marvell Technology from Neutral to Buy and raises the price target from $90 to $110
Needham initiates coverage on Itron ITRI at Buy rating and announces a price target of $124
Needham maintains Cooper Companies at Buy and raises the price target from $99 to $101
Keefe, Bruyette & Woods maintains Hippo Holdings HIPO at Market Perform and lowers the price target from $34 to $33
BTIG initiates coverage on SBC Medical Group Holding at Buy rating and announces a price target of $8
Needham maintains Grid Dynamics Holdings GDYN at Buy and lowers the price target from $13 to $10
BMO Capital upgrades Okta from Market Perform to Outperform and raises the price target from $83 to $97
Needham maintains AudioEye AEYE at Buy and lowers the price target from $25 to $15
B. Riley Securities downgrades Brilliant Earth Group from Buy to Neutral and lowers the price target from $3 to $1.5
BTIG maintains Costco Wholesale COST at Buy and raises the price target from $1115 to $1125
BTIG reiterates Strategy at Buy and maintains the price target at $250
Oppenheimer initiates coverage on Motorcar Parts of America MPAA at Outperform rating and announces a price target of $18
Baird upgrades Union Pacific from Neutral to Outperform and raises the price target from $239 to $311
Clear Street maintains Erasca ERAS at Buy and raises the price target from $11 to $20
Morgan Stanley downgrades AES from Overweight to Equal-Weight and lowers the price target from $23 to $15
Piper Sandler upgrades Karman Holdings KRMN from Neutral to Overweight and raises the price target from $110 to $127
3-5-2026
Citigroup maintains Arcus Biosciences at Buy and raises the price target from $44 to $45
Citigroup maintains Range Resources RRC at Neutral and raises the price target from $36 to $43
Citigroup maintains Matador Resources at Buy and raises the price target from $53 to $62
Citigroup maintains Darden Restaurants at Buy and raises the price target from $234 to $235
Citigroup maintains Cracker Barrel Old CBRL at Sell and raises the price target from $24 to $28
Citigroup maintains Arvinas at Buy and raises the price target from $15 to $18
Citigroup maintains Arvinas at Buy and raises the price target from $15 to $18
Citigroup maintains CrowdStrike Holdings CRWD at Buy and lowers the price target from $610 to $525
Citigroup maintains Lithia Motors at Buy and lowers the price target from $399 to $366
Citigroup maintains National Vision Holdings EYE at Buy and raises the price target from $35 to $40
Benchmark maintains APA at Buy and raises the price target from $33 to $40
Lake Street initiates coverage on SKYX Platforms SKYX at Buy rating and announces a price target of $5
Northland Capital Markets upgrades Mayville Engineering from Market Perform to Outperform and raises the price target from $20 to $25
Needham maintains Ciena CIEN at Buy and raises the price target from $280 to $370
B. Riley Securities maintains ClearPoint Neuro at Buy and lowers the price target from $28 to $18
B. Riley Securities maintains Hudson Technologies HDSN at Buy and lowers the price target from $10.5 to $9.5
B. Riley Securities maintains Eos Energy Enterprises at Neutral and lowers the price target from $12 to $8
B. Riley Securities maintains Alpha Metallurgical AMR at Neutral and raises the price target from $203 to $207
Piper Sandler maintains Permian Resources at Overweight and raises the price target from $20 to $24
Piper Sandler maintains Northern Oil & Gas NOG at Neutral and raises the price target from $25 to $27
Piper Sandler maintains Crescent Energy at Overweight and raises the price target from $13 to $14
Benchmark maintains Rigetti Computing RGTI at Buy and lowers the price target from $40 to $35
Piper Sandler maintains Chord Energy at Overweight and raises the price target from $151 to $158
Piper Sandler maintains Black Stone Minerals BSM at Neutral and raises the price target from $13 to $14
Wells Fargo maintains Lennox International at Equal-Weight and raises the price target from $520 to $560
Wells Fargo maintains Concentra Group Holdings CON at Overweight and raises the price target from $25 to $28
Wells Fargo maintains Wealthfront at Overweight and lowers the price target from $15.5 to $12.5
Wells Fargo maintains TriplePoint Venture Gwth TPVG at Underweight and lowers the price target from $5.5 to $5
Wells Fargo maintains Cracker Barrel Old at Equal-Weight and raises the price target from $30 to $35
Wells Fargo maintains National Vision Holdings EYE at Equal-Weight and raises the price target from $27 to $30
Wells Fargo maintains Carnival at Overweight and raises the price target from $38 to $40
Barclays maintains Sea SE at Overweight and lowers the price target from $226 to $120
Barclays maintains Public Service Enterprise at Equal-Weight and raises the price target from $81 to $89
Truist Securities maintains Riskified RSKD at Buy and lowers the price target from $8 to $7
Barclays maintains National Vision Holdings at Overweight and raises the price target from $32 to $38
Barclays maintains National Storage NSA at Equal-Weight and raises the price target from $33 to $38
Truist Securities maintains Omega Healthcare Invts at Hold and raises the price target from $46 to $48
Barclays maintains Kodiak Gas Services KGS at Overweight and raises the price target from $49 to $60
Truist Securities reiterates Okta at Buy and lowers the price target from $115 to $100
Barclays maintains Kinetik Holdings KNTK at Equal-Weight and raises the price target from $40 to $43
Barclays maintains Extra Space Storage at Overweight and raises the price target from $164 to $170
Barclays maintains DT Midstream DTM at Equal-Weight and raises the price target from $119 to $141
Barclays maintains CubeSmart at Equal-Weight and raises the price target from $43 to $45
RBC Capital maintains Rayonier Adv Materials RYAM at Outperform and raises the price target from $9 to $14
Barclays maintains Bath & Body Works BBWI at Equal-Weight and raises the price target from $21 to $25
UBS maintains Surgery Partners at Buy and lowers the price target from $29 to $21
RBC Capital maintains Morgan Stanley Direct MSDL at Sector Perform and lowers the price target from $18 to $16
RBC Capital maintains ChargePoint Hldgs at Sector Perform and lowers the price target from $9 to $6.5
UBS maintains Veeva Systems VEEV at Neutral and raises the price target from $200 to $220
Susquehanna maintains Baidu at Neutral and raises the price target from $110 to $120
UBS maintains Ovintiv OVV at Buy and raises the price target from $61 to $69
UBS maintains Iovance Biotherapeutics at Neutral and raises the price target from $2 to $4
UBS maintains Hasbro HAS at Buy and raises the price target from $99 to $110
UBS maintains ConocoPhillips at Buy and raises the price target from $130 to $144
UBS maintains Chord Energy CHRD at Buy and raises the price target from $119 to $142
UBS maintains Cracker Barrel Old at Neutral and raises the price target from $26 to $31
UBS maintains Antero Resources AR at Buy and raises the price target from $45 to $48
UBS maintains APA at Neutral and raises the price target from $34 to $36
Evercore ISI Group upgrades Southern SO from In-Line to Outperform and raises the price target from $103 to $111
Evercore ISI Group upgrades Public Service Enterprise PEG from In-Line to Outperform and raises the price target from $83 to $96
Evercore ISI Group downgrades Duke Energy DUK from Outperform to In-Line and lowers the price target from $143 to $139
Evercore ISI Group maintains Target at In-Line and raises the price target from $105 to $120
Evercore ISI Group maintains Stubhub Holdings at Outperform and lowers the price target from $27 to $14
Evercore ISI Group maintains Sempra SRE at Outperform and raises the price target from $105 to $107
Evercore ISI Group maintains PPL at Outperform and raises the price target from $43 to $44
Evercore ISI Group maintains Oracle ORCL at Outperform and lowers the price target from $275 to $220
Evercore ISI Group maintains NiSource at In-Line and raises the price target from $47 to $50
Evercore ISI Group maintains Montrose Environmental MEG at Outperform and raises the price target from $33 to $37
Evercore ISI Group maintains Incyte at In-Line and raises the price target from $73 to $110
Evercore ISI Group maintains First Solar FSLR at In-Line and lowers the price target from $241 to $212
Evercore ISI Group maintains Exelon at Outperform and raises the price target from $55 to $58
Evercore ISI Group maintains Entergy ETR at In-Line and raises the price target from $101 to $107
Evercore ISI Group maintains Consolidated Edison at In-Line and raises the price target from $106 to $117
Evercore ISI Group maintains Clearway Energy CWEN at In-Line and raises the price target from $34 to $39
Evercore ISI Group maintains CenterPoint Energy at In-Line and raises the price target from $42 to $44
Evercore ISI Group maintains Brown-Forman BF at In-Line and lowers the price target from $32 to $30
Evercore ISI Group maintains AZZ at Outperform and raises the price target from $128 to $137
Guggenheim maintains Starbucks at Neutral and raises the price target from $90 to $95
Guggenheim maintains National Vision Holdings EYE at Buy and raises the price target from $32 to $33
Evercore ISI Group maintains Broadcom AVGO at Outperform and raises the price target from $490 to $582
Evercore ISI Group maintains Archrock at Outperform and raises the price target from $35 to $42
Evercore ISI Group maintains American Electric Power AEP at Outperform and raises the price target from $137 to $153
Wedbush maintains MannKind at Outperform and lowers the price target from $10 to $8
Wedbush maintains TScan Therapeutics TCRX at Outperform and raises the price target from $4 to $5
Wedbush initiates coverage on Climb Bio at Outperform rating and announces a price target of $12
Mizuho maintains Viking Holdings VIK at Underperform and raises the price target from $59 to $69
Mizuho maintains Tronox Holdings at Underperform and raises the price target from $4 to $4.5
Mizuho maintains Chemours CC at Outperform and raises the price target from $17 to $21
Mizuho maintains Target at Neutral and raises the price target from $100 to $120
Mizuho maintains Surgery Partners SGRY at Outperform and lowers the price target from $19 to $17
Keybanc maintains Stevanato Group at Overweight and lowers the price target from $37 to $32
Keybanc maintains Okta OKTA at Overweight and lowers the price target from $115 to $100
Keybanc maintains Janus Intl at Overweight and lowers the price target from $12 to $9
Mizuho maintains Kinder Morgan KMI at Outperform and raises the price target from $31 to $37
Telsey Advisory Group downgrades Grocery Outlet Holding from Outperform to Market Perform and lowers the price target from $15 to $9
Keybanc maintains Dycom Industries DY at Overweight and raises the price target from $426 to $482
Telsey Advisory Group maintains Bath & Body Works at Market Perform and raises the price target from $23 to $25
Mizuho maintains Primo Brands PRMB at Outperform and raises the price target from $24 to $28
Mizuho maintains BellRing Brands at Outperform and lowers the price target from $40 to $34
Telsey Advisory Group maintains American Eagle Outfitters AEO at Market Perform and lowers the price target from $28 to $25
Mizuho maintains AutoZone at Neutral and raises the price target from $3550 to $3600
Mizuho maintains Apellis Pharmaceuticals APLS at Neutral and raises the price target from $19 to $20
Needham maintains Rigetti Computing at Buy and lowers the price target from $51 to $31
Morgan Stanley maintains Veeva Systems VEEV at Equal-Weight and raises the price target from $205 to $215
BTIG reiterates Abercrombie & Fitch at Buy and maintains the price target at $120
Benchmark reiterates Broadcom AVGO at Buy and maintains the price target at $485
Scotiabank upgrades MongoDB MDB from Sector Perform to Sector Outperform and raises the price target from $275 to $310
Citigroup upgrades Seadrill SDRL from Sell to Neutral and raises the price target from $32 to $46
Macquarie downgrades Tencent Music Enter from Outperform to Neutral and announces a price target of $14.1
Ladenburg Thalmann downgrades Edison International EIX from Neutral to Sell and announces a price target of $63
JP Morgan downgrades Stubhub Holdings from Overweight to Neutral and lowers the price target from $22 to $10
JP Morgan initiates coverage on Sunbelt Rentals Holdings, Inc. Common Stock SUNB at Neutral rating and announces a price target of $78
Stifel maintains Oculis Holding at Buy and raises the price target from $40 to $50
Bernstein initiates coverage on American Tower AMT at Market Perform rating and announces a price target of $205
Jefferies downgrades Grocery Outlet Holding GO from Buy to Hold and lowers the price target from $18 to $7
Stifel maintains Northwest Natural Hldg at Buy and raises the price target from $52 to $58
Rothschild & Co maintains Southwest Airlines LUV at Sell and raises the price target from $27 to $35
Stifel maintains MPLX at Buy and raises the price target from $57 to $59
Rothschild & Co maintains Delta Air Lines DAL at Buy and lowers the price target from $72 to $70
Stifel maintains AnaptysBio at Buy and raises the price target from $56 to $85
Rothschild & Co maintains United Airlines Holdings UAL at Buy and lowers the price target from $125 to $110
Rothschild & Co downgrades American Airlines Group AAL from Buy to Neutral and lowers the price target from $17 to $12.5
B of A Securities maintains Broadcom at Buy and lowers the price target from $500 to $450
HSBC initiates coverage on AGI AGBK at Buy rating and announces a price target of $15
Bernstein initiates coverage on Crown Castle at Outperform rating and announces a price target of $102
Truist Securities initiates coverage on Vanda Pharmaceuticals VNDA at Buy rating and announces a price target of $18
Bernstein initiates coverage on CoreWeave at Underperform rating and announces a price target of $56
Needham maintains Wix .com WIX at Buy and lowers the price target from $140 to $115
HC Wainwright & Co. maintains EyePoint at Buy and raises the price target from $23 to $30
BTIG maintains Shift4 Payments FOUR at Buy and lowers the price target from $80 to $70
Needham maintains Genius Sports at Buy and lowers the price target from $16 to $14
Needham maintains Veeva Systems VEEV at Buy and lowers the price target from $355 to $270
Mizuho upgrades Marriott Vacations VAC from Neutral to Outperform and raises the price target from $58 to $104
BMO Capital upgrades Westlake WLK from Market Perform to Outperform and raises the price target from $108 to $127
BMO Capital upgrades LyondellBasell Industries from Underperform to Market Perform and raises the price target from $38 to $68
BTIG maintains BillionToOne BLLN at Buy and lowers the price target from $160 to $140
BMO Capital upgrades Dow from Underperform to Market Perform and raises the price target from $22 to $35
BTIG reiterates Okta OKTA at Buy and maintains the price target at $90
BTIG reiterates Costco Wholesale at Buy and maintains the price target at $1115
Truist Securities maintains Genius Sports GENI at Buy and lowers the price target from $15 to $13
Loop Capital initiates coverage on Astera Labs at Buy rating and announces a price target of $250
Piper Sandler maintains Veeva Systems VEEV at Overweight and lowers the price target from $355 to $285
3-4-2026
Canaccord Genuity maintains Core Scientific at Buy and raises the price target from $17 to $20
JP Morgan maintains ACADIA Pharmaceuticals ACAD at Overweight and raises the price target from $31 to $34
Macquarie maintains CrowdStrike Holdings at Neutral and lowers the price target from $485 to $400
Barrington Research maintains American Public Education APEI at Outperform and raises the price target from $40 to $51
Canaccord Genuity maintains Upland Software at Buy and lowers the price target from $5 to $3
Canaccord Genuity maintains Passage Bio PASG at Buy and lowers the price target from $67 to $23
Canaccord Genuity maintains AeroVironment at Buy and lowers the price target from $400 to $330
Canaccord Genuity maintains Advantage Solutions ADV at Buy and lowers the price target from $2.5 to $1.5
Citigroup maintains Thor Industries at Neutral and lowers the price target from $116 to $100
Citigroup maintains CoreWeave CRWV at Buy and lowers the price target from $135 to $126
Citigroup maintains Autodesk at Buy and raises the price target from $315 to $331
Citigroup maintains Box BOX at Buy and lowers the price target from $40 to $36
Citigroup maintains Clarivate at Neutral and lowers the price target from $4.25 to $2.8
Citigroup maintains Venture Global VG at Neutral and raises the price target from $9 to $12
Citigroup maintains ADT at Buy and lowers the price target from $10 to $8.5
Citigroup maintains Scholar Rock Holding SRRK at Buy and raises the price target from $55 to $58
Citigroup maintains Target at Neutral and raises the price target from $110 to $117
Citigroup maintains Arcturus Therapeutics ARCT at Neutral and raises the price target from $7 to $8
Evercore ISI Group maintains Tidewater TDW at In-Line and raises the price target from $65 to $94
Evercore ISI Group maintains Marvell Technology at Outperform and lowers the price target from $156 to $133
Evercore ISI Group maintains Mirum Pharmaceuticals MIRM at Outperform and raises the price target from $101 to $126
Scotiabank maintains UDR at Sector Perform and raises the price target from $37 to $39
BNP Paribas maintains CrowdStrike Holdings CRWD at Neutral and lowers the price target from $450 to $400
Evercore ISI Group maintains B&G Foods at In-Line and raises the price target from $4.5 to $5
Evercore ISI Group maintains Best Buy Co BBY at In-Line and raises the price target from $70 to $75
Morgan Stanley maintains Teledyne Technologies at Equal-Weight and raises the price target from $620 to $680
Morgan Stanley maintains Target TGT at Overweight and raises the price target from $125 to $145
Morgan Stanley maintains Centene at Equal-Weight and raises the price target from $38 to $45
Morgan Stanley maintains BrightSpring Health BTSG at Overweight and raises the price target from $40 to $48
Morgan Stanley maintains AutoZone at Overweight and raises the price target from $4000 to $4020
B. Riley Securities maintains Ameresco AMRC at Buy and raises the price target from $45 to $47
Scotiabank maintains EQT at Sector Perform and raises the price target from $66 to $67
Goldman Sachs maintains Weatherford International WFRD at Neutral and raises the price target from $83 to $107
Goldman Sachs maintains TechnipFMC at Buy and raises the price target from $55 to $66
Goldman Sachs maintains Target TGT at Neutral and raises the price target from $91 to $112
Goldman Sachs maintains Sportradar at Neutral and lowers the price target from $35 to $24
Goldman Sachs maintains SLB SLB at Buy and raises the price target from $53 to $60
Goldman Sachs maintains Ross Stores at Buy and raises the price target from $214 to $244
Goldman Sachs maintains Patterson-UTI Energy PTEN at Buy and raises the price target from $7 to $9
Goldman Sachs maintains NOV at Sell and raises the price target from $17 to $20
UBS maintains Harley-Davidson HOG at Neutral and lowers the price target from $27 to $19
Goldman Sachs maintains MongoDB at Buy and lowers the price target from $475 to $320
Goldman Sachs maintains Liberty Energy LBRT at Neutral and raises the price target from $26 to $30
UBS maintains Target at Buy and raises the price target from $130 to $144
Goldman Sachs maintains Kontoor Brands KTB at Buy and raises the price target from $84 to $95
UBS maintains Methanex at Buy and raises the price target from $53 to $60
Goldman Sachs maintains Best Buy Co BBY at Buy and lowers the price target from $93 to $76
Goldman Sachs maintains Atlas Energy Solutions at Sell and raises the price target from $8 to $9
UBS maintains Kontoor Brands KTB at Buy and raises the price target from $118 to $131
UBS maintains AST SpaceMobile at Neutral and raises the price target from $43 to $85
Wells Fargo maintains Duke Energy DUK at Equal-Weight and raises the price target from $115 to $135
Truist Securities maintains Sun Communities at Buy and raises the price target from $141 to $147
Wells Fargo maintains Take-Two Interactive TTWO at Overweight and lowers the price target from $301 to $295
Truist Securities maintains Lineage at Buy and raises the price target from $41 to $44
Truist Securities maintains James River Hldgs JRVR at Hold and raises the price target from $6 to $7
Wells Fargo maintains Plug Power at Equal-Weight and raises the price target from $1.5 to $2
Wells Fargo maintains Sportradar SRAD at Overweight and lowers the price target from $26 to $24
RBC Capital maintains Paysafe at Sector Perform and lowers the price target from $10 to $9
Wells Fargo maintains Kontoor Brands KTB at Overweight and raises the price target from $95 to $100
Barclays maintains Ziff Davis at Equal-Weight and raises the price target from $34 to $45
RBC Capital maintains EVgo EVGO at Outperform and lowers the price target from $7 to $4.5
RBC Capital maintains Oracle at Sector Perform and lowers the price target from $195 to $160
Barclays maintains Scholar Rock Holding SRRK at Overweight and raises the price target from $52 to $53
Barclays maintains RXO at Overweight and raises the price target from $15 to $17
Barclays maintains Ross Stores at Overweight and raises the price target from $221 to $242
Barclays maintains On Holding ONON at Overweight and lowers the price target from $60 to $57
Truist Securities maintains Best Buy Co at Hold and lowers the price target from $73 to $66
Barclays maintains Marex Group MRX at Overweight and raises the price target from $49 to $50
Barclays maintains Latham Group at Equal-Weight and raises the price target from $7 to $8
Barclays maintains Kontoor Brands KTB at Overweight and raises the price target from $74 to $93
Barclays maintains Knight-Swift at Overweight and raises the price target from $65 to $75
Barclays maintains Honeywell Intl HON at Overweight and raises the price target from $259 to $275
Barclays maintains Diamondback Energy at Overweight and raises the price target from $178 to $185
Barclays maintains BioMarin Pharmaceutical BMRN at Overweight and raises the price target from $80 to $105
Barclays maintains AnaptysBio at Overweight and raises the price target from $78 to $79
Barclays maintains Adobe ADBE at Overweight and lowers the price target from $415 to $335
Truist Securities maintains Accel Entertainment at Hold and raises the price target from $13 to $14
Oppenheimer maintains Target TGT at Outperform and raises the price target from $130 to $140
Oppenheimer maintains PACS Group at Outperform and raises the price target from $40 to $42
Oppenheimer maintains Nerdwallet NRDS at Outperform and lowers the price target from $18 to $15
Keybanc maintains WEC Energy Group at Overweight and raises the price target from $117 to $126
Keybanc maintains Exelon EXC at Underweight and raises the price target from $39 to $44
Piper Sandler reiterates ImmunityBio at Overweight and raises the price target from $7 to $12
Keybanc maintains Entergy ETR at Overweight and raises the price target from $102 to $111
Piper Sandler maintains Target at Neutral and raises the price target from $102 to $119
Keybanc maintains Consolidated Edison ED at Underweight and raises the price target from $86 to $96
Piper Sandler reiterates Teva Pharmaceutical Indus at Overweight and raises the price target from $40 to $41
Keybanc maintains CenterPoint Energy CNP at Overweight and raises the price target from $41 to $47
Guggenheim maintains Best Buy Co at Buy and maintains the price target at $90
Stifel maintains Viking Holdings VIK at Buy and raises the price target from $85 to $90
Guggenheim maintains Gray Media at Buy and raises the price target from $7 to $8
Stifel maintains Latham Group SWIM at Buy and raises the price target from $8.75 to $9.5
Telsey Advisory Group maintains On Holding at Outperform and maintains the price target at $65
Guggenheim maintains Target TGT at Buy and raises the price target from $125 to $130
Guggenheim maintains Ross Stores at Buy and raises the price target from $199 to $226
Guggenheim maintains Dianthus Therapeutics DNTH at Buy and raises the price target from $100 to $200
Guggenheim maintains Maze Therapeutics at Buy and raises the price target from $46 to $58
Stifel maintains Enterprise Prods Partners EPD at Buy and raises the price target from $38 to $41
Stifel maintains Civeo at Buy and raises the price target from $33 to $37
Mizuho maintains Welltower WELL at Outperform and raises the price target from $216 to $231
Cantor Fitzgerald maintains EVgo at Overweight and lowers the price target from $7 to $6
Keefe, Bruyette & Woods maintains LendingTree TREE at Outperform and lowers the price target from $83 to $70
Bernstein maintains CrowdStrike Holdings at Market Perform and raises the price target from $353 to $368
Bernstein maintains Sea SE at Outperform and lowers the price target from $170 to $150
Bernstein upgrades Target TGT from Underperform to Market Perform and raises the price target from $91 to $116
Mizuho maintains Ventas at Outperform and raises the price target from $87 to $94
Mizuho maintains HASI HASI at Outperform and raises the price target from $34 to $41
GLJ Research downgrades First Solar FSLR from Buy to Hold and lowers the price target from $314.43 to $207.82
JP Morgan downgrades Vulcan Materials VMC from Overweight to Neutral and lowers the price target from $335 to $320
JP Morgan upgrades Cementos Pacasmayo CPAC from Underweight to Neutral and raises the price target from $7.5 to $13
Morgan Stanley maintains Viking Holdings at Overweight and raises the price target from $75 to $79
DA Davidson initiates coverage on Roblox RBLX at Neutral rating and announces a price target of $65
Morgan Stanley maintains Norwegian Cruise Line at Equal-Weight and lowers the price target from $25 to $24
Morgan Stanley maintains CrowdStrike Holdings CRWD at Equal-Weight and lowers the price target from $537 to $487
HC Wainwright & Co. maintains Roivant Sciences at Buy and raises the price target from $33 to $34
Benchmark maintains Semtech SMTC at Buy and raises the price target from $85 to $115
Keybanc upgrades Dow from Sector Weight to Overweight and announces a price target of $38
B of A Securities maintains Target TGT at Underperform and raises the price target from $103 to $106
Needham maintains Lumentum Holdings at Buy and raises the price target from $550 to $850
Needham maintains Coherent COHR at Buy and raises the price target from $235 to $330
Piper Sandler downgrades GitLab from Overweight to Neutral and lowers the price target from $55 to $28
Needham maintains Upstart Holdings UPST at Buy and lowers the price target from $56 to $40
Baird initiates coverage on nLight at Outperform rating and announces a price target of $95
BTIG maintains Sportradar SRAD at Buy and lowers the price target from $32 to $24
BTIG maintains Kontoor Brands at Buy and raises the price target from $95 to $100
Truist Securities initiates coverage on Lennar LEN at Hold rating and announces a price target of $110
BTIG maintains FIGS at Buy and raises the price target from $15 to $20
Needham maintains CryoPort CYRX at Buy and raises the price target from $12 to $13
Clear Street maintains MARA Holdings MARA at Hold and lowers the price target from $16 to $9
B of A Securities maintains Saia at Neutral and raises the price target from $413 to $429
3-3-2026
Ladenburg Thalmann maintains Red Cat Holdings RCAT at Buy and raises the price target from $15 to $20
Freedom Capital Markets downgrades Douglas Dynamics PLOW from Buy to Hold and raises the price target from $39 to $48
Canaccord Genuity maintains Life360 at Buy and lowers the price target from $115 to $94
Canaccord Genuity maintains Ameresco AMRC at Buy and raises the price target from $44 to $50
JP Morgan maintains CRH at Overweight and raises the price target from $135 to $140
JP Morgan maintains Ferrari RACE at Overweight and raises the price target from $407 to $447
UBS maintains Kymera Therapeutics at Buy and raises the price target from $90 to $128
UBS maintains EchoStar SATS at Neutral and raises the price target from $125 to $127
UBS maintains Asana at Neutral and lowers the price target from $16 to $9
Needham maintains Esperion Therapeutics ESPR at Buy and raises the price target from $4 to $5
Citigroup maintains Cactus at Buy and raises the price target from $55 to $63
BTIG maintains Paysafe PSFE at Buy and lowers the price target from $11 to $10
Citigroup maintains Newmont at Buy and raises the price target from $118 to $150
Lake Street maintains Crexendo CXDO at Buy and raises the price target from $8.5 to $9
Citigroup maintains Catalyst Pharmaceuticals at Buy and raises the price target from $33 to $35
Lake Street maintains Dave DAVE at Buy and raises the price target from $308 to $326
Piper Sandler reiterates Cigna Group at Overweight and lowers the price target from $374 to $370
Stifel maintains MYR Group MYRG at Buy and raises the price target from $262 to $305
Stifel maintains Scotts Miracle Gro at Buy and raises the price target from $70 to $79
Stifel maintains Proficient Auto Logistics PAL at Buy and lowers the price target from $12 to $10
Stifel maintains Zymeworks at Buy and raises the price target from $40 to $47
Morgan Stanley maintains Targa Resources TRGP at Overweight and raises the price target from $266 to $298
Morgan Stanley maintains Restaurant Brands Intl at Equal-Weight and raises the price target from $77 to $78
Morgan Stanley maintains Kinder Morgan KMI at Equal-Weight and raises the price target from $34 to $36
Morgan Stanley maintains Ingram Micro Holding at Equal-Weight and raises the price target from $21 to $23
Morgan Stanley maintains Belite Bio BLTE at Overweight and raises the price target from $191 to $201
GLJ Research reiterates Sunrun at Sell and announces a price target of $6.73
B. Riley Securities maintains Diversified Healthcare DHC at Buy and raises the price target from $6.5 to $8.5
Leerink Partners maintains Ionis Pharmaceuticals at Outperform and raises the price target from $102 to $104
B. Riley Securities maintains Dave DAVE at Buy and raises the price target from $297 to $303
B. Riley Securities maintains Compass Diversified Hldgs at Neutral and lowers the price target from $13 to $8
Barclays maintains Rubrik RBRK at Overweight and lowers the price target from $100 to $70
Barclays maintains Qorvo QRVO at Equal-Weight and raises the price target from $90 to $95
Truist Securities maintains Flywire at Buy and lowers the price target from $17 to $16
Barclays maintains Omada Health OMDA at Overweight and lowers the price target from $22 to $17
HC Wainwright & Co. maintains US Goldmining at Buy and raises the price target from $26.5 to $30.75
Truist Securities maintains COPT Defense Props CDP at Hold and raises the price target from $31 to $33
Barclays maintains Lumentum Holdings at Equal-Weight and raises the price target from $475 to $750
Barclays maintains Innovex International INVX at Equal-Weight and raises the price target from $20 to $24
RBC Capital maintains Nuvation Bio at Outperform and raises the price target from $12 to $13
Barclays maintains Heartland Express HTLD at Underweight and raises the price target from $9 to $10
Barclays maintains First Solar at Overweight and lowers the price target from $279 to $228
RBC Capital maintains Biohaven BHVN at Outperform and raises the price target from $22 to $23
RBC Capital maintains Ascendis Pharma at Outperform and raises the price target from $250 to $275
Barclays maintains Coca-Cola Femsa SAB de KOF at Equal-Weight and raises the price target from $110 to $112
Barclays maintains Cirrus Logic at Equal-Weight and raises the price target from $110 to $120
RBC Capital maintains AeroVironment AVAV at Outperform and lowers the price target from $375 to $325
Barclays maintains CF Industries Holdings CF at Overweight and raises the price target from $100 to $120
Barclays maintains California Resources at Overweight and raises the price target from $65 to $67
RBC Capital initiates coverage on Ormat Technologies ORA at Outperform rating and announces a price target of $130
Oppenheimer maintains XPO at Outperform and raises the price target from $198 to $228
Oppenheimer maintains AAON at Outperform and raises the price target from $115 to $118
Needham upgrades Core Scientific from Hold to Buy and announces a price target of $23
Goldman Sachs maintains PAR Technology PAR at Neutral and lowers the price target from $40 to $18
Wells Fargo maintains Commercial Metals at Overweight and raises the price target from $79 to $80
Wells Fargo maintains Intellia Therapeutics NTLA at Equal-Weight and raises the price target from $12 to $15
Wells Fargo maintains Septerna at Overweight and raises the price target from $28 to $48
Wedbush maintains Larimar Therapeutics LRMR at Outperform and raises the price target from $11 to $12
Goldman Sachs maintains MYR Group at Neutral and raises the price target from $248 to $296
Wedbush maintains Apogee Therapeutics APGE at Outperform and raises the price target from $90 to $95
Goldman Sachs maintains uniQure at Neutral and lowers the price target from $37 to $9
Goldman Sachs maintains Protagonist Therapeutics PTGX at Neutral and raises the price target from $65 to $95
Craig-Hallum maintains Eton Pharmaceuticals at Buy and raises the price target from $29 to $30
Guggenheim maintains Sionna Therapeutics SION at Buy and raises the price target from $45 to $50
Guggenheim maintains Paramount Skydance at Neutral and raises the price target from $11 to $14
Cantor Fitzgerald maintains Valley Ntl VLY at Overweight and raises the price target from $15 to $16
Cantor Fitzgerald maintains Core Scientific at Overweight and lowers the price target from $26 to $25
Cantor Fitzgerald maintains Quantum Computing QUBT at Neutral and lowers the price target from $15 to $10
Cantor Fitzgerald maintains Riot Platforms at Overweight and lowers the price target from $31 to $29
Wells Fargo initiates coverage on Check Point Software CHKP at Equal-Weight rating and announces a price target of $165
Wells Fargo initiates coverage on Zscaler at Overweight rating and announces a price target of $200
Wells Fargo initiates coverage on Netskope at Overweight rating and announces a price target of $13
Wells Fargo initiates coverage on Okta OKTA at Equal-Weight rating and announces a price target of $76
Cantor Fitzgerald maintains BigBear.ai Hldgs at Neutral and lowers the price target from $6 to $5
Cantor Fitzgerald maintains HubSpot HUBS at Overweight and raises the price target from $280 to $325
Cantor Fitzgerald maintains MongoDB at Overweight and lowers the price target from $454 to $378
Susquehanna initiates coverage on Carpenter Technology CRS at Positive rating and announces a price target of $470
Susquehanna maintains Norwegian Cruise Line at Neutral and lowers the price target from $21 to $20
Wells Fargo initiates coverage on Fortinet FTNT at Underweight rating and announces a price target of $64
Cantor Fitzgerald maintains Ryman Hospitality Props at Overweight and raises the price target from $108 to $115
Susquehanna maintains Credo Technology Group CRDO at Positive and lowers the price target from $230 to $170
Wells Fargo initiates coverage on CrowdStrike Holdings at Overweight rating and announces a price target of $450
Cantor Fitzgerald maintains Pebblebrook Hotel PEB at Neutral and raises the price target from $12 to $14
Wells Fargo initiates coverage on Palo Alto Networks at Overweight rating and announces a price target of $200
Cantor Fitzgerald maintains Host Hotels & Resorts HST at Neutral and raises the price target from $19 to $21
Wells Fargo initiates coverage on Varonis Systems at Overweight rating and announces a price target of $28
Wells Fargo initiates coverage on SailPoint SAIL at Overweight rating and announces a price target of $17
Oppenheimer maintains Teladoc Health at Outperform and lowers the price target from $12 to $7
Keybanc maintains Asana ASAN at Overweight and lowers the price target from $18 to $15
Keybanc maintains Cava Group at Overweight and raises the price target from $65 to $95
Keybanc maintains Helios Technologies HLIO at Overweight and raises the price target from $74 to $82
Keybanc maintains McDonald’s at Overweight and raises the price target from $340 to $354
Mizuho maintains Nomad Foods at Outperform and lowers the price target from $15 to $13
Mizuho maintains MasTec MTZ at Outperform and raises the price target from $254 to $362
Citigroup initiates coverage on SpyGlass Pharma at Buy rating and announces a price target of $42
Mizuho maintains Lyft LYFT at Neutral and lowers the price target from $16 to $15
JP Morgan initiates coverage on Once Upon a Farm at Overweight rating and announces a price target of $29
JP Morgan initiates coverage on AgomAb Therapeutics AGMB at Overweight rating and announces a price target of $32
Jones Trading initiates coverage on iBio at Buy rating and announces a price target of $7
Mizuho maintains DoorDash DASH at Outperform and lowers the price target from $320 to $255
Mizuho maintains Circle Internet Group at Neutral and raises the price target from $90 to $100
Mizuho maintains BrightSpring Health BTSG at Outperform and raises the price target from $45 to $50
Canaccord Genuity maintains Dave at Buy and raises the price target from $274 to $328
Citizens maintains Intellia Therapeutics NTLA at Market Outperform and raises the price target from $21 to $28
HSBC upgrades Block XYZ from Hold to Buy and raises the price target from $70 to $77
Northland Capital Markets upgrades 1stdibs.com from Market Perform to Outperform and maintains the price target at $7
Bernstein maintains GE Aerospace GE at Outperform and raises the price target from $374 to $405
Bernstein downgrades Sabre from Outperform to Market Perform and announces a price target of $1.5
Baird maintains Asana ASAN at Neutral and lowers the price target from $16 to $9
Telsey Advisory Group maintains ThredUp at Outperform and lowers the price target from $12 to $9
HC Wainwright & Co. maintains Dyne Therapeutics DYN at Buy and lowers the price target from $60 to $50
Mizuho downgrades uniQure from Outperform to Neutral and lowers the price target from $33 to $12
Needham maintains Archer Aviation ACHR at Buy and lowers the price target from $10 to $9
B of A Securities maintains Norwegian Cruise Line at Neutral and lowers the price target from $30 to $27
Needham maintains LendingTree TREE at Buy and lowers the price target from $85 to $60
Needham maintains Riot Platforms RIOT at Buy and lowers the price target from $30 to $24
B of A Securities upgrades Unity Software from Underperform to Neutral and raises the price target from $18 to $19
BTIG maintains Netstreit NTST at Buy and raises the price target from $19 to $22
B of A Securities initiates coverage on Once Upon a Farm at Buy rating and announces a price target of $26
Keefe, Bruyette & Woods maintains Dave DAVE at Outperform and raises the price target from $250 to $295
HC Wainwright & Co. maintains Riot Platforms at Buy and lowers the price target from $26 to $23
Needham reiterates Credo Technology Group CRDO aAT Buy and maintains the price target at $220
Baird downgrades MongoDB from Outperform to Neutral and lowers the price target from $500 to $260
Stifel initiates coverage on SpyGlass Pharma SGP at Buy rating and announces a price target of $42
Morgan Stanley initiates coverage on AgomAb Therapeutics at Overweight rating and announces a price target of $28
Keefe, Bruyette & Woods downgrades BlackRock TCP Cap TCPC from Market Perform to Underperform and lowers the price target from $7 to $3.5
Clear Street maintains Ocular Therapeutix at Buy and raises the price target from $21 to $28
Goldman Sachs initiates coverage on Once Upon a Farm OFRM at Buy rating and announces a price target of $43
Stifel initiates coverage on Amylyx Pharmaceuticals at Buy rating and announces a price target of $21
Piper Sandler maintains AeroVironment AVAV at Overweight and lowers the price target from $391 to $290
Piper Sandler maintains Asana ASAN at Overweight and lowers the price target from $14 to $9
3-2-2026
Citigroup maintains Ducommun DCO at Buy and raises the price target from $125 to $143
Citigroup maintains Sun Communities at Buy and raises the price target from $150 to $155
Citigroup maintains Ecovyst ECVT at Neutral and raises the price target from $12 to $13
Canaccord Genuity maintains Redwire at Buy and raises the price target from $11 to $12
JP Morgan maintains Ciena CIEN at Overweight and raises the price target from $250 to $380
Scotiabank maintains Ventas at Sector Perform and raises the price target from $80 to $93
Baird maintains CrowdStrike Holdings CRWD at Neutral and lowers the price target from $550 to $450
Scotiabank maintains Netstreit at Sector Outperform and raises the price target from $21 to $22
Baird maintains MasTec MTZ at Outperform and raises the price target from $249 to $348
Argus Research upgrades Pfizer from Hold to Buy and announces a price target of $35
Scotiabank maintains Gildan Activewear GIL at Sector Outperform and raises the price target from $72 to $74
Stifel maintains Global Partners at Hold and raises the price target from $45 to $46
Stifel maintains VSE VSEC at Buy and raises the price target from $250 to $260
Stifel maintains Sight Sciences at Buy and raises the price target from $6 to $8
Scotiabank maintains Extra Space Storage EXR at Sector Perform and raises the price target from $145 to $156
Piper Sandler reiterates Autodesk at Overweight and raises the price target from $373 to $383
Scotiabank maintains Dominion Energy D at Sector Perform and raises the price target from $63 to $67
Goldman Sachs maintains Zscaler ZS at Neutral and lowers the price target from $290 to $257
Goldman Sachs maintains V2X at Sell and raises the price target from $57 to $63
Goldman Sachs maintains Brink’s BCO at Buy and raises the price target from $129 to $145
Goldman Sachs maintains Sunrun at Buy and raises the price target from $21 to $24
Goldman Sachs maintains Sprout Social SPT at Neutral and lowers the price target from $13 to $8
Goldman Sachs maintains Shift4 Payments at Neutral and lowers the price target from $81 to $56
Goldman Sachs maintains Rocket Pharmaceuticals RCKT at Sell and raises the price target from $2 to $3
Goldman Sachs maintains Ramaco Resources at Sell and lowers the price target from $16 to $14
Goldman Sachs maintains Playtika Holding PLTK at Neutral and lowers the price target from $4.75 to $4.25
Goldman Sachs maintains NuScale Power at Neutral and lowers the price target from $20 to $14
Goldman Sachs maintains Macerich MAC at Sell and raises the price target from $15 to $17
Goldman Sachs maintains Kodiak Gas Services at Buy and raises the price target from $46 to $60
Goldman Sachs maintains Intuit INTU at Neutral and lowers the price target from $720 to $519
Goldman Sachs maintains Imax at Neutral and raises the price target from $37 to $41
Goldman Sachs maintains Grindr at Buy and lowers the price target from $20 to $17
Goldman Sachs maintains GoodRx Holdings GDRX at Neutral and lowers the price target from $4 to $2.5
RBC Capital maintains Qnity Electronics at Outperform and raises the price target from $133 to $139
Morgan Stanley maintains Marvell Technology MRVL at Equal-Weight and lowers the price target from $112 to $95
RBC Capital maintains MoonLake at Sector Perform and raises the price target from $12 to $13
Morgan Stanley maintains First Solar FSLR at Overweight and lowers the price target from $275 to $230
RBC Capital maintains Diversified Healthcare at Sector Perform and raises the price target from $5 to $6
RBC Capital maintains CubeSmart CUBE at Outperform and raises the price target from $43 to $46
Wells Fargo maintains DoubleVerify Holdings at Underweight and raises the price target from $8 to $9
Wells Fargo maintains Lineage LINE at Equal-Weight and raises the price target from $32 to $39
Morgan Stanley maintains CRH at Overweight and raises the price target from $140 to $141
Wells Fargo maintains Gray Media at Equal-Weight and raises the price target from $5.5 to $6
Wells Fargo maintains Steel Dynamics STLD at Overweight and raises the price target from $190 to $210
Wells Fargo maintains Reliance at Equal-Weight and raises the price target from $315 to $323
Wells Fargo maintains Commercial Metals CMC at Overweight and raises the price target from $79 to $80
Wells Fargo maintains Verisk Analytics at Overweight and raises the price target from $223 to $240
Wells Fargo maintains Disc Medicine IRON at Overweight and raises the price target from $78 to $79
Morgan Stanley maintains BrightView Hldgs at Equal-Weight and raises the price target from $13 to $14
Morgan Stanley maintains AutoNation AN at Overweight and raises the price target from $233 to $238
Morgan Stanley maintains AerCap Holdings at Equal-Weight and raises the price target from $150 to $160
Barclays maintains Vale VALE at Overweight and raises the price target from $15.5 to $16.5
Goldman Sachs maintains Figure Technology at Buy and lowers the price target from $49 to $44
Goldman Sachs maintains Duolingo DUOL at Neutral and lowers the price target from $250 to $105
Goldman Sachs maintains Celldex Therapeutics at Neutral and raises the price target from $30 to $34
Goldman Sachs maintains Banco Macro BMA at Buy and lowers the price target from $111 to $98
Barclays maintains Tanger at Equal-Weight and raises the price target from $36 to $38
Barclays maintains Seadrill SDRL at Equal-Weight and raises the price target from $39 to $41
Barclays maintains Regency Centers at Overweight and raises the price target from $82 to $85
Barclays maintains Primo Brands PRMB at Overweight and raises the price target from $21 to $27
Barclays maintains Ormat Technologies at Overweight and raises the price target from $108 to $123
Barclays maintains National Vision Holdings EYE at Overweight and raises the price target from $30 to $32
Barclays maintains Hawaiian Electric Indus at Equal-Weight and raises the price target from $13 to $14
Barclays maintains Excelerate Energy EE at Overweight and raises the price target from $33 to $41
Barclays maintains Coupang at Overweight and raises the price target from $23 to $24
Barclays maintains Cactus WHD at Overweight and raises the price target from $56 to $62
Keybanc maintains RBC Bearings at Overweight and raises the price target from $595 to $680
Barclays maintains Burlington Stores BURL at Overweight and raises the price target from $331 to $335
Barclays maintains Bath & Body Works at Equal-Weight and raises the price target from $20 to $21
Keybanc maintains CMS Energy CMS at Overweight and raises the price target from $79 to $83
Keybanc maintains Advanced Energy Indus at Overweight and raises the price target from $330 to $375
Barclays maintains ACV Auctions ACVA at Equal-Weight and lowers the price target from $8 to $7
HC Wainwright & Co. maintains TRX Gold at Buy and raises the price target from $1.5 to $2.3
Truist Securities maintains Shake Shack SHAK at Buy and raises the price target from $144 to $148
Wells Fargo downgrades AZZ from Overweight to Equal-Weight and raises the price target from $127 to $132
Citigroup initiates coverage on Veradermics MANE at Buy rating and announces a price target of $85
Truist Securities maintains Regency Centers at Buy and raises the price target from $77 to $84
Truist Securities maintains Privia Health PRVA at Buy and raises the price target from $31 to $33
Stifel maintains 10x Genomics at Buy and raises the price target from $20 to $25
HC Wainwright & Co. maintains AtaiBeckley ATAI at Buy and raises the price target from $15 to $25
Truist Securities maintains OrthoPediatrics at Hold and raises the price target from $19 to $20
Truist Securities maintains MasTec MTZ at Buy and raises the price target from $270 to $356
Barclays downgrades Blue Owl Capital from Overweight to Equal-Weight and lowers the price target from $15 to $11
Needham maintains Viavi Solutions VIAV at Buy and raises the price target from $28 to $36
Truist Securities maintains Lantheus Holdings at Buy and raises the price target from $82 to $89
Truist Securities maintains Amneal Pharmaceuticals AMRX at Buy and raises the price target from $15 to $17
Barclays upgrades JetBlue Airways from Underweight to Equal-Weight and raises the price target from $4 to $7
Mizuho maintains Target TGT at Neutral and raises the price target from $88 to $100
Mizuho maintains Sunrun at Outperform and lowers the price target from $25 to $22
Mizuho maintains Intuit INTU at Outperform and lowers the price target from $675 to $600
Jefferies upgrades Marriott Vacations from Hold to Buy and raises the price target from $52 to $105
Mizuho maintains Dentsply Sirona XRAY at Neutral and raises the price target from $14 to $16
B of A Securities maintains Exxon Mobil at Neutral and raises the price target from $135 to $151
Barrington Research maintains Outfront Media OUT at Outperform and raises the price target from $27 to $33
B of A Securities maintains Chevron at Buy and raises the price target from $188 to $206
Telsey Advisory Group maintains a.k.a. Brands Holding AKA at Market Perform and maintains the price target at $13
Telsey Advisory Group maintains Brilliant Earth Group at Market Perform and maintains the price target at $2
BTIG maintains Opus Genetics IRD at Buy and raises the price target from $7 to $12
Goldman Sachs initiates coverage on Bobs Discount Furniture at Neutral rating and announces a price target of $25
Telsey Advisory Group maintains Victoria’s Secret VSCO at Outperform and raises the price target from $66 to $71
Telsey Advisory Group maintains Olaplex Hldgs at Market Perform and maintains the price target at $2
Goldman Sachs upgrades Dutch Bros BROS from Neutral to Buy and maintains the price target at $75
Goldman Sachs downgrades Novo Nordisk from Buy to Neutral and lowers the price target from $63 to $41
BTIG maintains Denali Therapeutics DNLI at Buy and raises the price target from $32 to $36
Goldman Sachs upgrades Frontdoor from Sell to Neutral and raises the price target from $50 to $67
Goldman Sachs initiates coverage on Forgent Power Solutions at Buy rating and announces a price target of $48
B of A Securities initiates coverage on Eikon Therapeutics EIKN at Buy rating and announces a price target of $34
Piper Sandler upgrades CrowdStrike Holdings from Neutral to Overweight and maintains the price target at $520
Needham maintains NIQ Global Intelligence NIQ at Buy and lowers the price target from $24 to $21
Stifel downgrades Aardvark Therapeutics AARD from Buy to Hold and lowers the price target from $24 to $6
Stifel upgrades Restaurant Brands Intl QSR from Hold to Buy and raises the price target from $68 to $90
Morgan Stanley upgrades Flywire from Equal-Weight to Overweight and raises the price target from $15 to $17
Morgan Stanley initiates coverage on Eikon Therapeutics EIKN at Overweight rating and announces a price target of $32
TD Cowen upgrades Twilio TWLO from Hold to Buy and raises the price target from $125 to $160
Morgan Stanley initiates coverage on Forgent Power Solutions at Equal-Weight rating and announces a price target of $38
Morgan Stanley initiates coverage on Bobs Discount Furniture BOBS at Overweight rating and announces a price target of $25.5
Piper Sandler maintains Bentley Systems at Neutral and lowers the price target from $45 to $42
Ascendiant Capital initiates coverage on NextTrip $NTRP at Buy rating and announces a price target of $7
BTIG maintains SailPoint at Buy and lowers the price target from $29 to $22
BTIG maintains Okta OKTA at Buy and lowers the price target from $116 to $90
BTIG maintains Netskope at Buy and lowers the price target from $27 to $22
BTIG maintains CrowdStrike Holdings CRWD at Buy and lowers the price target from $640 to $499
BTIG maintains Nomad Foods at Buy and lowers the price target from $18 to $15
2-27-2026
TD Cowen maintains Block at Buy and raises the price target from $91 to $95
RBC Capital maintains VSE VSEC at Outperform and raises the price target from $225 to $250
Wells Fargo maintains Sempra at Overweight and raises the price target from $112 to $113
Canaccord Genuity maintains Arbe Robotics ARBE at Buy and lowers the price target from $1.75 to $1.25
Canaccord Genuity maintains DoubleVerify Holdings at Buy and lowers the price target from $18 to $16
Seaport Global maintains Wolverine World Wide WWW at Buy and raises the price target from $24 to $28
Rothschild & Co upgrades Live Nation Entertainment LYV from Neutral to Buy and raises the price target from $166 to $193
Wedbush downgrades NCR Atleos from Outperform to Neutral and raises the price target from $45 to $50.4
TD Cowen maintains Warner Bros. Discovery WBD at Hold and raises the price target from $22 to $26
Canaccord Genuity maintains Hut 8 at Buy and raises the price target from $62 to $70
Benchmark maintains Lindblad Expeditions LIND at Buy and raises the price target from $18 to $25
Truist Securities maintains AMERISAFE at Hold and lowers the price target from $45 to $36
Benchmark maintains Gray Media GTN at Buy and raises the price target from $10 to $12
Benchmark maintains Nexstar Media at Buy and raises the price target from $250 to $300
Piper Sandler maintains Ionis Pharmaceuticals IONS at Overweight and raises the price target from $87 to $100
Piper Sandler maintains TWFG at Overweight and raises the price target from $22 to $24
Piper Sandler maintains Lineage LINE at Neutral and raises the price target from $41 to $43
Piper Sandler reiterates Dell Technologies at Overweight and lowers the price target from $172 to $167
Wells Fargo maintains Teleflex TFX at Equal-Weight and raises the price target from $116 to $130
Bernstein maintains JM Smucker at Market Perform and raises the price target from $113 to $121
Wells Fargo maintains Agilon Health AGL at Overweight and raises the price target from $1 to $1.5
Oppenheimer maintains Zscaler at Outperform and lowers the price target from $345 to $280
Stephens & Co. maintains Hormel Foods HRL at Equal-Weight and raises the price target from $25 to $27
Wells Fargo maintains Rocket Companies at Equal-Weight and raises the price target from $17 to $19
Wells Fargo maintains Kinetik Holdings KNTK at Equal-Weight and raises the price target from $40 to $44
Oppenheimer maintains Sunrun at Outperform and raises the price target from $23 to $25
Oppenheimer maintains Sensata Technologies ST at Outperform and raises the price target from $43 to $50
Wells Fargo maintains Excelerate Energy at Equal-Weight and raises the price target from $29 to $39
Oppenheimer maintains Ligand Pharmaceuticals LGND at Outperform and raises the price target from $275 to $277
Guggenheim maintains BeOne Medicines at Buy and raises the price target from $400 to $410
Guggenheim maintains Arcutis Biotherapeutics ARQT at Buy and raises the price target from $34 to $35
Wells Fargo maintains Archrock at Overweight and raises the price target from $30 to $39
Wells Fargo maintains Shake Shack SHAK at Equal-Weight and raises the price target from $90 to $100
Wells Fargo maintains Target at Overweight and raises the price target from $115 to $130
Guggenheim maintains Nautilus Biotechnology NAUT at Buy and raises the price target from $2.5 to $4
Wells Fargo maintains BJ’s Wholesale Club Hldgs at Overweight and raises the price target from $105 to $110
Wells Fargo maintains Restaurant Brands Intl QSR at Equal-Weight and raises the price target from $70 to $75
Wells Fargo maintains JM Smucker at Overweight and raises the price target from $120 to $135
Wells Fargo maintains Monster Beverage MNST at Overweight and raises the price target from $86 to $94
Wells Fargo maintains Marriott Vacations at Underweight and raises the price target from $46 to $58
Barclays maintains LivaNova LIVN at Equal-Weight and raises the price target from $67 to $73
Barclays maintains LandBridge at Equal-Weight and raises the price target from $57 to $75
Barclays maintains FTAI Aviation FTAI at Overweight and raises the price target from $260 to $350
Barclays maintains Elastic at Overweight and lowers the price target from $78 to $76
Oppenheimer maintains Carlisle Companies CSL at Outperform and raises the price target from $400 to $435
Oppenheimer maintains Block at Outperform and raises the price target from $85 to $89
Barclays maintains Cheniere Energy LNG at Overweight and raises the price target from $259 to $271
Barclays maintains C4 Therapeutics at Overweight and raises the price target from $5 to $7
Barclays maintains Dell Technologies at Overweight and raises the price target from $148 to $168
Keefe, Bruyette & Woods maintains Payoneer Global PAYO at Outperform and lowers the price target from $7.5 to $7
Keefe, Bruyette & Woods maintains Shift4 Payments at Market Perform and lowers the price target from $72 to $60
DA Davidson maintains CoreWeave CRWV at Buy and raises the price target from $110 to $125
Keefe, Bruyette & Woods maintains Fidelis Insurance Hldgs at Outperform and raises the price target from $26 to $26.5
Keefe, Bruyette & Woods maintains Figure Technology FIGR at Outperform and lowers the price target from $62 to $55
Cantor Fitzgerald maintains Zai Lab at Overweight and lowers the price target from $55 to $37
Cantor Fitzgerald maintains Universal Health Services UHS at Neutral and lowers the price target from $250 to $229
Cantor Fitzgerald maintains TeraWulf at Overweight and raises the price target from $18 to $24
Cantor Fitzgerald reiterates Block XYZ at Overweight and maintains the price target at $70
Evercore ISI Group maintains Dentsply Sirona at In-Line and raises the price target from $12 to $15
Cantor Fitzgerald maintains Rocket Pharmaceuticals RCKT at Overweight and raises the price target from $8 to $10
Cantor Fitzgerald maintains MARA Holdings at Overweight and lowers the price target from $21 to $11
Cantor Fitzgerald maintains Nuvalent NUVL at Overweight and raises the price target from $135 to $140
Evercore ISI Group maintains Bristow Group at Outperform and raises the price target from $45 to $56
Evercore ISI Group maintains TORM TRMD at Outperform and raises the price target from $28 to $34
Cantor Fitzgerald maintains Centuri Holdings at Overweight and raises the price target from $34 to $35.25
Cantor Fitzgerald maintains nLight LASR at Overweight and raises the price target from $40 to $62.5
Cantor Fitzgerald maintains AvePoint at Overweight and lowers the price target from $18 to $15
Cantor Fitzgerald reiterates CoreWeave CRWV at Overweight and maintains the price target at $131
Evercore ISI Group maintains Tapestry at Outperform and raises the price target from $170 to $180
Cantor Fitzgerald maintains Realty Income O at Neutral and raises the price target from $60 to $68
Cantor Fitzgerald maintains GitLab at Neutral and lowers the price target from $40 to $30
Evercore ISI Group maintains Natera NTRA at Outperform and raises the price target from $250 to $260
Evercore ISI Group maintains National Storage at Underperform and raises the price target from $31 to $33
Cantor Fitzgerald maintains Okta OKTA at Overweight and lowers the price target from $115 to $100
Cantor Fitzgerald maintains Rocket Lab at Overweight and raises the price target from $72 to $85
Evercore ISI Group maintains Monster Beverage MNST at Outperform and raises the price target from $85 to $90
Cantor Fitzgerald maintains PureCycle Technologies at Overweight and lowers the price target from $16 to $14
Evercore ISI Group maintains Installed Building Prods IBP at In-Line and raises the price target from $265 to $326
Evercore ISI Group maintains Flowco Holdings at Outperform and raises the price target from $25 to $28
Citizens maintains USA Today Co TDAY at Market Outperform and raises the price target from $6 to $8
Evercore ISI Group maintains Edgewise Therapeutics at Outperform and raises the price target from $30 to $45
Citizens maintains Rhythm Pharmaceuticals RYTM at Market Outperform and raises the price target from $167 to $176
Evercore ISI Group maintains Krispy Kreme at In-Line and raises the price target from $3 to $4.5
Citizens maintains Lantheus Holdings LNTH at Market Outperform and raises the price target from $78 to $85
Wells Fargo upgrades Sun Communities SUI from Equal-Weight to Overweight and raises the price target from $133 to $150
Wells Fargo upgrades Liberty Media from Underweight to Equal-Weight and raises the price target from $93 to $95
Evercore ISI Group maintains TopBuild BLD at In-Line and raises the price target from $448 to $471
Wells Fargo upgrades PENN Entertainment from Underweight to Equal-Weight and raises the price target from $15 to $16
Evercore ISI Group maintains AutoZone AZO at Outperform and raises the price target from $4100 to $4125
Citizens maintains argenx at Market Outperform and raises the price target from $925 to $944
Keybanc maintains Wolverine World Wide WWW at Overweight and raises the price target from $24 to $25
Keybanc maintains Solventum at Overweight and raises the price target from $97 to $99
Keybanc maintains Qnity Electronics Q at Overweight and raises the price target from $117 to $147
Keybanc maintains Middleby at Overweight and raises the price target from $175 to $190
Keybanc maintains Ecovyst ECVT at Overweight and raises the price target from $11 to $14
JP Morgan downgrades Cars.com from Overweight to Neutral and lowers the price target from $16 to $10
Guggenheim maintains Nexstar Media at Buy and raises the price target from $250 to $290
Baird maintains Dentsply Sirona XRAY at Neutral and raises the price target from $12 to $14
Baird maintains Natera at Outperform and raises the price target from $239 to $257
Baird maintains Castle Biosciences CSTL at Outperform and raises the price target from $41 to $44
Baird maintains Caris Life Sciences at Outperform and raises the price target from $26 to $28
Baird maintains argenx ARGX at Neutral and raises the price target from $858 to $867
Bernstein upgrades Newmont NEM from Market Perform to Market Outperform and raises the price target from $121 to $157
Baird maintains Wolverine World Wide at Outperform and raises the price target from $23 to $27
Baird maintains Shake Shack SHAK at Neutral and raises the price target from $104 to $108
Baird maintains RealReal at Neutral and raises the price target from $15 to $16
Needham maintains nLight LASR at Buy and raises the price target from $48 to $70
Needham maintains Block at Buy and raises the price target from $80 to $90
Piper Sandler maintains Monster Beverage MNST at Overweight and raises the price target from $85 to $94
Needham maintains Applied Optoelectronics at Buy and raises the price target from $43 to $80
Mizuho maintains Ryan Specialty Holdings RYAN at Neutral and lowers the price target from $53 to $44
Needham maintains PAR Technology at Buy and lowers the price target from $55 to $30
Needham maintains OrthoPediatrics KIDS at Buy and raises the price target from $26 to $30
Needham maintains Personalis at Buy and raises the price target from $10 to $12
HC Wainwright & Co. maintains argenx ARGX at Buy and raises the price target from $915 to $940
Mizuho downgrades Marsh from Outperform to Neutral and lowers the price target from $213 to $199
HC Wainwright & Co. maintains Novavax NVAX at Buy and raises the price target from $11 to $16
Roth Capital maintains Eos Energy Enterprises at Neutral and lowers the price target from $12 to $6
BTIG maintains Autodesk ADSK at Buy and lowers the price target from $365 to $300
Mizuho upgrades Brown & Brown BRO from Neutral to Outperform and raises the price target from $84 to $85
B of A Securities upgrades Aon AON from Neutral to Outperform and lowers the price target from $398 to $397
Citigroup downgrades Dollar Tree from Buy to Neutral and maintains the price target at $132
Needham maintains Sprout Social SPT at Buy and lowers the price target from $32 to $14
BTIG reiterates Block at Buy and maintains the price target at $90
Needham maintains Figure Technology at Buy and lowers the price target from $71 to $55
BTIG maintains Flutter Entertainment FLUT at Buy and lowers the price target from $230 to $180
B. Riley Securities upgrades Applied Optoelectronics AAOI from Sell to Neutral and raises the price target from $15 to $54
B. Riley Securities upgrades PubMatic PUBM from Neutral to Buy and raises the price target from $10 to $10.5
Morgan Stanley upgrades Block XYZ from Equal-Weight to Overweight and raises the price target from $72 to $93
BTIG maintains OrthoPediatrics at Buy and raises the price target from $23 to $24
BTIG reiterates FTAI Infrastructure FIP at Buy and maintains the price target at $10
Morgan Stanley downgrades Duolingo DUOL from Overweight to Equal-Weight and lowers the price target from $245 to $100
Morgan Stanley downgrades Vital Farms from Overweight to Equal-Weight and lowers the price target from $45 to $24
2-26-2026
DA Davidson maintains Clear Secure at Buy and raises the price target from $46 to $54
Citigroup maintains TechnipFMC FTI at Buy and raises the price target from $48 to $76
Macquarie maintains AMC Entertainment Hldgs AMC at Neutral and lowers the price target from $2 to $1.5
DA Davidson maintains Douglas Dynamics at Buy and raises the price target from $48 to $55
DA Davidson maintains Zeta Global Holdings ZETA at Buy and raises the price target from $29 to $30
JP Morgan maintains Target at Neutral and raises the price target from $100 to $115
Citigroup maintains Ethos Technologies at Buy and raises the price target from $15 to $16
Citigroup maintains APi Group APG at Buy and raises the price target from $49 to $52
Citigroup maintains Toll Brothers at Neutral and raises the price target from $141 to $162
Citigroup maintains Bloomin Brands BLMN at Neutral and raises the price target from $6.75 to $7
Oppenheimer maintains Flutter Entertainment FLUT at Outperform and lowers the price target from $280 to $210
Oppenheimer maintains Nutrien at Outperform and raises the price target from $76 to $78
Bernstein maintains Zoom Communications ZM at Market Perform and lowers the price target from $90 to $88
Piper Sandler maintains PROCEPT BioRobotics at Overweight and lowers the price target from $50 to $28
Piper Sandler maintains Kymera Therapeutics KYMR at Overweight and raises the price target from $125 to $140
Piper Sandler maintains Select Water Solutions at Overweight and raises the price target from $14 to $16
Wells Fargo maintains Clear Secure YOU at Underweight and raises the price target from $29 to $33
Piper Sandler reiterates Lowe’s Companies at Overweight and raises the price target from $294 to $300
RBC Capital maintains Trade Desk TTD at Outperform and lowers the price target from $65 to $40
Wells Fargo maintains Ibotta at Equal-Weight and raises the price target from $30 to $34
Wells Fargo maintains Sinclair SBGI at Equal-Weight and raises the price target from $16 to $17
Wells Fargo maintains Westlake at Equal-Weight and raises the price target from $70 to $100
Wells Fargo maintains Primoris Services PRIM at Equal-Weight and raises the price target from $138 to $168
Wells Fargo maintains Centuri Holdings at Overweight and raises the price target from $30 to $34
Wells Fargo maintains LeMaitre Vascular LMAT at Equal-Weight and raises the price target from $87 to $94
Wells Fargo maintains Revolution Medicines at Overweight and raises the price target from $100 to $144
Wells Fargo maintains Agilent Technologies A at Overweight and lowers the price target from $175 to $165
Wells Fargo maintains Globus Medical at Overweight and raises the price target from $98 to $104
Wells Fargo maintains Alkermes ALKS at Overweight and raises the price target from $37 to $43
RBC Capital maintains TaskUs at Sector Perform and lowers the price target from $17 to $13
Wells Fargo maintains RxSight RXST at Equal-Weight and lowers the price target from $13 to $11
Evercore ISI Group maintains Teladoc Health at In-Line and lowers the price target from $8 to $5
Evercore ISI Group maintains Sun Communities SUI at Outperform and raises the price target from $141 to $146
Wells Fargo maintains Root at Equal-Weight and lowers the price target from $75 to $70
Evercore ISI Group maintains Tanger SKT at In-Line and raises the price target from $36 to $37
Wells Fargo maintains Range Resources at Equal-Weight and raises the price target from $43 to $46
Evercore ISI Group maintains Penumbra PEN at Outperform and raises the price target from $340 to $360
Wells Fargo maintains First Solar at Overweight and lowers the price target from $285 to $255
RBC Capital maintains Medline MDLN at Outperform and raises the price target from $47 to $53
Wells Fargo maintains Viking Holdings at Equal-Weight and raises the price target from $62 to $77
Barclays maintains Xencor XNCR at Overweight and raises the price target from $26 to $27
Evercore ISI Group maintains Lineage with a In-Line and raises the price target from $38 to $39
Barclays maintains Universal Health Services UHS at Overweight and raises the price target from $262 to $268
Barclays maintains TJX Companies at Overweight and raises the price target from $172 to $183
Barclays maintains Solaris Energy SEI at Overweight and raises the price target from $61 to $63
Benchmark maintains Sinclair at Buy and raises the price target from $27 to $30
Barclays maintains Sensata Technologies ST at Overweight and raises the price target from $40 to $44
Benchmark maintains Imax at Buy and raises the price target from $42 to $44
Barclays maintains Everpure PSTG at Equal-Weight and raises the price target from $77 to $81
Barclays maintains Protagonist Therapeutics PTGX at Overweight and raises the price target from $108 to $113
Barclays maintains Keurig Dr Pepper at Equal-Weight and raises the price target from $30 to $32
Barclays maintains BJ’s Restaurants BJRI at Underweight and raises the price target from $39 to $42
Evercore ISI Group maintains APA at In-Line and raises the price target from $21 to $25
Barclays maintains Atlas Energy Solutions AESI at Underweight and raises the price target from $7 to $8
Wedbush maintains C3.ai at Outperform and lowers the price target from $20 to $15
Barclays maintains Alkami Technology ALKT at Equal-Weight and lowers the price target from $25 to $21
Barclays maintains APi Group at Overweight and raises the price target from $44 to $52
Barclays maintains Align Technology ALGN at Equal-Weight and raises the price target from $170 to $200
Barclays maintains Agilent Technologies at Overweight and lowers the price target from $165 to $150
Citizens maintains Ironwood Pharmaceuticals IRWD at Market Outperform and raises the price target from $8 to $10
Wells Fargo upgrades Alcon from Equal-Weight to Overweight and raises the price target from $88 to $97
Citizens maintains Encore Capital ECPG at Market Outperform and raises the price target from $75 to $90
Citigroup downgrades Ategrity Specialty ASIC from Buy to Neutral and announces a price target of $27
Citizens maintains ACADIA Pharmaceuticals at Market Outperform and raises the price target from $34 to $35
Keybanc maintains Zoom Communications ZM at Underweight and raises the price target from $69 to $74
Stifel maintains Mirum Pharmaceuticals at Buy and raises the price target from $98 to $125
Stifel maintains Marriott Vacations VAC at Buy and raises the price target from $77 to $85
Keybanc maintains LifeStance Health at Overweight and raises the price target from $8 to $9
Stifel maintains Intapp INTA at Buy and lowers the price target from $40 to $35
Keybanc maintains Applied Industrial Techs at Overweight and raises the price target from $300 to $330
Stifel reiterates Hayward Holdings HAYW at Buy and raises the price target from $19 to $19.5
Compass Point downgrades Tanger from Buy to Neutral and announces a price target of $38
Stifel maintains Clear Secure YOU at Hold and raises the price target from $38 to $51
Stifel reiterates Celldex Therapeutics at Buy and raises the price target from $58 to $68
Stifel maintains Archrock AROC at Buy and raises the price target from $31 to $40
BTIG maintains BWX Technologies at Buy and raises the price target from $225 to $235
Truist Securities maintains Trade Desk TTD at Buy and lowers the price target from $60 to $50
Truist Securities maintains Snowflake at Buy and lowers the price target from $270 to $240
BTIG maintains V2X VVX at Buy and raises the price target from $80 to $90.
Truist Securities maintains SPX Technologies at Hold and raises the price target from $216 to $244
Truist Securities maintains Nerdwallet NRDS at Buy and lowers the price target from $19 to $18
Truist Securities maintains Encore Capital ECPG at Buy and raises the price target from $59 to $80
Truist Securities maintains APi Group at Buy and raises the price target from $50 to $53
BTIG maintains GitLab GTLB at Buy and lowers the price target from $52 to $32
Needham maintains Alkami Technology at Buy and lowers the price target from $32 to $22
Needham maintains Hut 8 HUT at Buy and raises the price target from $60 to $66
Needham maintains Snowflake at Buy and lowers the price target from $280 to $200
Telsey Advisory Group maintains TJX Companies TJX at Outperform and raises the price target from $170 to $175
Telsey Advisory Group maintains Urban Outfitters at Outperform and maintains the price target at $98
Telsey Advisory Group maintains Clear Secure YOU at Outperform and raises the price target from $45 to $55
Telsey Advisory Group maintains Zevia at Outperform and lowers the price target from $6 to $5
Needham maintains Veracyte VCYT at Buy and raises the price target from $44 to $48
Deutsche Bank downgrades Array Technologies from Buy to Hold and lowers the price target from $11 to $9
B of A Securities maintains Nutanix NTNX at Buy and lowers the price target from $75 to $60
BTIG maintains TJX Companies TJX at Buy and raises the price target from $165 to $185
Truist Securities upgrades U.S. Bancorp from Hold to Buy and raises the price target from $61 to $66
BTIG maintains CareDx CDNA at Buy and raises the price target from $25 to $26
BTIG maintains Vaxcyte at Buy and raises the price target from $85 to $89
Needham maintains Ionis Pharmaceuticals at Buy and raises the price target from $90 to $103
Needham maintains Alcon ALC at Buy and raises the price target from $98 to $100
B of A Securities downgrades Vale from Buy to Neutral and raises the price target from $17 to $18
B of A Securities downgrades Southern Copper from Neutral to Underperform and raises the price target from $162 to $175
B. Riley Securities downgrades Spok Holdings from Buy to Neutral and lowers the price target from $21 to $14
Loop Capital downgrades Trade Desk from Buy to Hold and lowers the price target from $75 to $25
Piper Sandler maintains Synopsys SNPS at Neutral and lowers the price target from $520 to $430
Deutsche Bank downgrades First Solar FSLR from Buy to Hold and lowers the price target from $300 to $245
Piper Sandler maintains Snowflake at Overweight and lowers the price target from $285 to $230
2-25-2026
UBS maintains Marqeta MQ at Neutral and lowers the price target from $5 to $4.25
Citigroup maintains Borr Drilling at Neutral and raises the price target from $6 to $6.25
Citigroup maintains Viper Energy at Buy and raises the price target from $45 to $52
Citigroup maintains Macerich MAC at Neutral and raises the price target from $19 to $21
Citigroup maintains Allison Transmission at Neutral and raises the price target from $110 to $130
Citigroup maintains Cava Group CAVA at Neutral and raises the price target from $74 to $75
Citigroup maintains AMC Entertainment Hldgs at Sell and lowers the price target from $1.3 to $1.1
Citigroup maintains Boston Beer Co SAM at Neutral and raises the price target from $220 to $230
Citigroup maintains Keysight Techs at Buy and raises the price target from $220 to $282
Citigroup maintains Corning GLW at Buy and raises the price target from $120 to $170
Oppenheimer maintains Ferguson Enterprises at Outperform and raises the price target from $255 to $280
JP Morgan maintains Planet Fitness PLNT at Overweight and lowers the price target from $120 to $105
Truist Securities maintains Astronics at Buy and raises the price target from $75 to $107
JP Morgan maintains TransMedics Group TMDX at Neutral and raises the price target from $114 to $149
Mizuho maintains Westlake at Neutral and raises the price target from $88 to $97
Mizuho maintains Primoris Services PRIM at Neutral and raises the price target from $128 to $143
HSBC downgrades First Solar FSLR from Buy to Hold and lowers the price target from $280 to $211
Goldman Sachs maintains Workday at Neutral and lowers the price target from $238 to $206
Mizuho maintains Establishment Labs Hldgs ESTA at Outperform and raises the price target from $90 to $100
Bernstein maintains BioMarin Pharmaceutical at Outperform and raises the price target from $90 to $94
Goldman Sachs maintains HP HPQ at Sell and lowers the price target from $21 to $16
Goldman Sachs maintains Grupo Cibest at Neutral and raises the price target from $69 to $76
Bernstein maintains Home Depot HD at Market Perform and raises the price target from $381 to $390
Goldman Sachs maintains Flywire at Neutral and lowers the price target from $17 to $15
Goldman Sachs maintains DigitalOcean Holdings DOCN at Buy and raises the price target from $50 to $78
Bernstein maintains Warner Bros. Discovery at Market Perform and raises the price target from $23.5 to $27.75
Goldman Sachs maintains CoStar Group CSGP at Buy and lowers the price target from $84 to $73
Bernstein maintains Cava Group at Outperform and raises the price target from $75 to $84
Needham maintains LivaNova LIVN at Buy and raises the price target from $64 to $81
Goldman Sachs maintains Chemours at Neutral and raises the price target from $14 to $18
Goldman Sachs maintains CCC Intelligent Solutions CCC at Neutral and lowers the price target from $9.5 to $7
Scotiabank maintains Iamgold at Sector Perform and raises the price target from $23 to $25
Goldman Sachs maintains Boise Cascade BCC at Neutral and raises the price target from $85 to $94
Goldman Sachs maintains Advanced Micro Devices at Neutral and raises the price target from $210 to $240
Goldman Sachs maintains ACV Auctions ACV at Buy and lowers the price target from $13 to $10
BTIG maintains Alcon at Buy and raises the price target from $91 to $92
Scotiabank maintains Anglogold Ashanti AU at Sector Outperform and raises the price target from $131 to $134
Barclays maintains Vir Biotechnology at Overweight and raises the price target from $26 to $30
Barclays maintains Trex Co TREX at Underweight and raises the price target from $32 to $39
Barclays maintains ProPetro Holding at Equal-Weight and raises the price target from $11 to $12
Barclays maintains Ovintiv OVV at Overweight and raises the price target from $55 to $58
Barclays maintains Humana at Equal-Weight and lowers the price target from $245 to $176
RBC Capital maintains Quaker Houghton KWR at Outperform and lowers the price target from $190 to $184
RBC Capital maintains Planet Fitness at Outperform and lowers the price target from $130 to $120
Morgan Stanley maintains V2X VVX at Underweight and raises the price target from $61 to $66
RBC Capital maintains GoDaddy at Outperform and lowers the price target from $200 to $100
Morgan Stanley maintains Resideo Technologies REZI at Overweight and raises the price target from $42 to $50
Barclays maintains Ferguson Enterprises at Overweight and raises the price target from $278 to $295
RBC Capital maintains Galapagos GLPG at Sector Perform and raises the price target from $32 to $33
Barclays maintains DigitalOcean Holdings DOCN at Overweight and raises the price target from $63 to $69
RBC Capital maintains Flywire at Outperform and raises the price target from $18 to $20
Morgan Stanley maintains Lam Research LRCX at Equal-Weight and raises the price target from $244 to $254
Morgan Stanley maintains Jazz Pharmaceuticals at Overweight and raises the price target from $225 to $226
Morgan Stanley maintains HP HPQ at Underweight and lowers the price target from $18 to $16
Barclays maintains Axon Enterprise at Overweight and lowers the price target from $702 to $682
Morgan Stanley maintains Home Depot HD at Overweight and raises the price target from $412 to $420
Morgan Stanley maintains Elanco Animal Health at Equal-Weight and raises the price target from $22 to $24
Morgan Stanley maintains Applied Materials AMAT at Overweight and raises the price target from $420 to $432
RBC Capital maintains First Solar at Outperform and lowers the price target from $258 to $236
RBC Capital reiterates Advanced Micro Devices AMD at Sector Perform and maintains the price target at $230
Wells Fargo maintains Caterpillar at Overweight and raises the price target from $756 to $870
RBC Capital maintains Qnity Electronics Q at Outperform and raises the price target from $118 to $133
Wells Fargo maintains Ferguson Enterprises at Overweight and raises the price target from $280 to $285
RBC Capital initiates coverage on Pfizer PFE at Underperform rating and announces a price target of $25
Roth Capital reiterates InfuSystems Holdings at Buy and raises the price target from $14 to $15
Roth Capital reiterates Revolve RVLV at Buy and raises the price target from $30 to $33
Roth Capital maintains AMC Entertainment Hldgs at Neutral and lowers the price target from $2 to $1.5
Citizens maintains DigitalOcean Holdings DOCN at Market Outperform and raises the price target from $60 to $83
Piper Sandler maintains Cava Group at Overweight and raises the price target from $71 to $85
Evercore ISI Group maintains TransMedics Group TMDX at Outperform and raises the price target from $155 to $170
Evercore ISI Group maintains Revolve at In-Line and raises the price target from $21 to $27
Guggenheim maintains Tarsus Pharmaceuticals TARS at Buy and raises the price target from $87 to $90
Guggenheim maintains Krystal Biotech at Buy and raises the price target from $224 to $284
Evercore ISI Group maintains Henry Schein HSIC at Outperform and raises the price target from $90 to $100
Evercore ISI Group maintains Equinix at Outperform and raises the price target from $960 to $1060
Evercore ISI Group maintains CrowdStrike Holdings CRWD at In-Line and lowers the price target from $460 to $375
Wells Fargo maintains Aflac at Equal-Weight and raises the price target from $109 to $118
Evercore ISI Group maintains BridgeBio Pharma BBIO at Outperform and raises the price target from $100 to $125
Guggenheim maintains Home Depot at Buy and raises the price target from $400 to $425
Evercore ISI Group maintains Armstrong World Indus AWI at In-Line and raises the price target from $189 to $191
Evercore ISI Group maintains Amer Sports at Outperform and raises the price target from $50 to $51
Guggenheim maintains Primoris Services PRIM at Buy and raises the price target from $160 to $170
Evercore ISI Group maintains Arvinas at Outperform and raises the price target from $14 to $19
Wells Fargo maintains Sunoco SUN at Overweight and raises the price target from $65 to $67
Evercore ISI Group maintains Advanced Micro Devices at Outperform and raises the price target from $328 to $358
Guggenheim maintains Shoals Technologies SHLS at Buy and lowers the price target from $12 to $11
Wells Fargo maintains Freshpet at Overweight and raises the price target from $82 to $90
Keefe, Bruyette & Woods maintains Toll Brothers TOL at Market Perform and raises the price target from $143 to $170
Cantor Fitzgerald maintains DigitalOcean Holdings at Overweight and raises the price target from $68 to $83
Wells Fargo maintains Home Depot HD at Overweight and raises the price target from $395 to $420
Cantor Fitzgerald reiterates Workday at Overweight and maintains the price target at $200
Cantor Fitzgerald maintains Lucid Group LCID at Neutral and lowers the price target from $21 to $14
Susquehanna maintains First Solar at Positive and lowers the price target from $292 to $280
Susquehanna maintains Diamondback Energy FANG at Positive and raises the price target from $182 to $199
Wedbush maintains Day One Biopharmaceutical DAWN at Outperform and raises the price target from $29 to $30
Wells Fargo upgrades Lincoln National LNC from Equal-Weight to Overweight and raises the price target from $41 to $48
Wedbush maintains Arvinas at Neutral and raises the price target from $9 to $11
Wedbush maintains Beam Therapeutics BEAM at Outperform and raises the price target from $57 to $65
Wedbush maintains Kiniksa Pharmaceuticals at Outperform and raises the price target from $50 to $53
Wedbush reiterates NetApp NTAP at Neutral and maintains the price target at $115
Wells Fargo initiates coverage on Live Nation Entertainment at Overweight rating and announces a price target of $204
Telsey Advisory Group maintains Home Depot HD at Outperform and raises the price target from $410 to $435
UBS initiates coverage on CEVA at Buy rating and announces a price target of $27
RBC Capital initiates coverage on Merck & Co MRK at Outperform rating and announces a price target of $142
Mizuho maintains Advanced Micro Devices at Outperform and raises the price target from $275 to $280
Citigroup initiates coverage on Galaxy Digital GLXY at Neutral rating and announces a price target of $25
B of A Securities maintains Jazz Pharmaceuticals at Buy and raises the price target from $263 to $275
Citizens maintains Cytokinetics CYTK at Market Outperform and raises the price target from $88 to $96
Jefferies upgrades Enphase Energy from Hold to Buy and raises the price target from $42 to $57
Oppenheimer upgrades Oracle ORCL from Perform to Outperform and announces a price target of $185
B of A Securities maintains Dycom Industries at Buy and raises the price target from $365 to $475
Benchmark reiterates Advanced Micro Devices AMD at Buy and maintains the price target at $325
Needham maintains Shoals Technologies at Buy and lowers the price target from $14 to $12
B of A Securities maintains DigitalOcean Holdings DOCN at Buy and raises the price target from $72 to $86
B of A Securities downgrades Fox from Buy to Underperform and lowers the price target from $80 to $45
BTIG maintains Revolve RVLV at Buy and raises the price target from $30 to $35
Baird downgrades First Solar FSLR from Outperform to Neutral and lowers the price target from $264 to $205
TD Cowen maintains Cava Group at Buy and raises the price target from $85 to $90
Stifel initiates coverage on Alumis ALMS at Buy rating and announces a price target of $44
Needham maintains Cipher Mining at Buy and lowers the price target from $26 to $22
Stifel initiates coverage on Palisade Bio PALI at Buy rating and announces a price target of $5
BTIG reiterates DexCom at Buy and maintains the price target at $85
B. Riley Securities initiates coverage on Angel Studios ANGX at Buy rating and announces a price target of $7
Needham maintains TransMedics Group at Buy and raises the price target from $166 to $174
Needham maintains Cytokinetics CYTK at Buy and raises the price target from $84 to $85
Oppenheimer initiates coverage on Bioage Labs at Outperform rating and announces a price target of $60
Needham maintains CECO Environmental CECO at Buy and raises the price target from $75 to $80
B of A Securities maintains Harmony Biosciences Hldgs at Underperform and lowers the price target from $32 to $28
BTIG maintains Palvella Therapeutics PVLA at Buy and raises the price target from $192 to $215
2-24-2026
JP Morgan maintains Freshpet at Neutral and raises the price target from $70 to $80
Jefferies maintains Quanta Services PWR at Buy and raises the price target from $506 to $634
JP Morgan maintains Yum Brands at Overweight and raises the price target from $160 to $170
JP Morgan maintains McDonald’s MCD at Overweight and raises the price target from $305 to $325
UBS maintains Axsome Therapeutics at Buy and raises the price target from $248 to $251
UBS maintains CF Industries Holdings CF at Neutral and raises the price target from $86 to $97
UBS maintains Keysight Techs at Buy and raises the price target from $230 to $340
UBS maintains Stryker SYK at Neutral and raises the price target from $386 to $400
Citigroup maintains DT Midstream at Buy and raises the price target from $130 to $156
Citigroup maintains Targa Resources at Buy and raises the price target from $200 to $262
Citigroup maintains ORIC Pharmaceuticals ORIC at Buy and raises the price target from $16 to $17
Citigroup maintains Nabors Industries at Neutral and raises the price target from $60 to $85
Citigroup maintains Host Hotels & Resorts HST at Buy and raises the price target from $19 to $22
Citigroup maintains YETI Holdings at Buy and raises the price target from $44 to $53
Roth Capital reiterates Clearway Energy CWEN at Buy and raises the price target from $40 to $45
Roth Capital maintains Ovintiv at Neutral and raises the price target from $42 to $50
Roth Capital reiterates New Pacific Metals NEWP at Buy and raises the price target from $4.25 to $6
Citigroup maintains Telix Pharmaceuticals at Buy and raises the price target from $22 to $22.5
Citigroup maintains Domino’s Pizza DPZ at Neutral and raises the price target from $420 to $440
Morgan Stanley maintains The Vita Coco Co at Equal-Weight and raises the price target from $49 to $57
Morgan Stanley maintains Vir Biotechnology VIR at Overweight and raises the price target from $20 to $24
Morgan Stanley maintains Stanley Black & Decker at Equal-Weight and raises the price target from $80 to $87
Maxim Group initiates coverage on Scienture Holdings SCNX at Buy rating and announces a price target of $1.5
Canaccord Genuity maintains Middleby at Buy and raises the price target from $175 to $187
Canaccord Genuity maintains Kratos Defense & Security KTOS at Buy and raises the price target from $120 to $125
Morgan Stanley maintains Flywire at Equal-Weight and lowers the price target from $16 to $15
Morgan Stanley maintains Deere DE at Overweight and raises the price target from $560 to $730
Goldman Sachs maintains Quanta Services at Buy and raises the price target from $495 to $685
Goldman Sachs maintains Paymentus Holdings PAY at Neutral and lowers the price target from $37 to $32
Goldman Sachs maintains Keysight Techs at Buy and raises the price target from $243 to $322
TD Cowen maintains Freshpet FRPT at Hold and raises the price target from $61 to $80
B. Riley Securities maintains United States Antimony UAMY at Buy and raises the price target from $9 to $11
B. Riley Securities maintains Lincoln Educational Servs at Buy and raises the price target from $33 to $38
B. Riley Securities reiterates Gladstone Commercial GOOD at Neutral and raises the price target from $11 to $12.5
TD Cowen maintains CrowdStrike Holdings at Buy and lowers the price target from $580 to $480
TD Cowen maintains Consolidated Edison ED at Hold and raises the price target from $105 to $112
B. Riley Securities maintains Century Aluminum at Buy and raises the price target from $64 to $68
Piper Sandler maintains Guardant Health GH at Overweight and raises the price target from $120 to $130
Goldman Sachs maintains MediaAlpha at Neutral and lowers the price target from $13.5 to $11.5
Goldman Sachs maintains Antero Midstream AM at Neutral and raises the price target from $18 to $23
Piper Sandler maintains NeoGenomics at Overweight and raises the price target from $12 to $13
Piper Sandler maintains Labcorp Hldgs LH at Neutral and raises the price target from $270 to $300
Guggenheim maintains Spotify Technology at Buy and lowers the price target from $720 to $600
RBC Capital maintains Welltower WELL at Outperform and raises the price target from $207 to $230
Stifel maintains ONE Gas at Hold and raises the price target from $88 to $90
RBC Capital reiterates Domino’s Pizza DPZ at Sector Perform and maintains the price target at $425
Stifel maintains Freshpet at Buy and raises the price target from $65 to $84
RBC Capital maintains Clearway Energy CWEN at Outperform and raises the price target from $38 to $42
RBC Capital maintains Monster Beverage at Outperform and raises the price target from $83 to $88
Truist Securities reiterates V2X VVX at Hold and raises the price target from $65 to $68
Truist Securities reiterates SI-BONE at Buy and raises the price target from $23 to $24
RBC Capital maintains Gildan Activewear GIL at Outperform and raises the price target from $71 to $79
Scotiabank maintains Targa Resources at Sector Outperform and raises the price target from $224 to $246
Keefe, Bruyette & Woods maintains Lemonade LMND at Underperform and raises the price target from $40 to $44
Evercore ISI Group maintains FedEx at In-Line and raises the price target from $364 to $380
BWS Financial maintains Adeia ADEA at Buy and raises the price target from $24 to $30
Evercore ISI Group maintains Domino’s Pizza at Outperform and raises the price target from $490 to $510
Evercore ISI Group maintains Vir Biotechnology VIR at Outperform and raises the price target from $12 to $18
Evercore ISI Group maintains Casey’s General Stores at Outperform and raises the price target from $660 to $665
Evercore ISI Group maintains Academy Sports ASO at In-Line and raises the price target from $55 to $60
Wells Fargo maintains Keysight Techs at Overweight and raises the price target from $225 to $300
Wells Fargo maintains Lamar Advertising LAMR at Equal-Weight and raises the price target from $121 to $136
Wells Fargo maintains Axsome Therapeutics at Overweight and raises the price target from $193 to $202
Wells Fargo maintains Exxon Mobil XOM at Overweight and raises the price target from $156 to $183
Oppenheimer maintains Nordson at Outperform and raises the price target from $285 to $325
Oppenheimer maintains MoonLake MLTX at Outperform and raises the price target from $30 to $35
Citizens maintains Axogen at Market Outperform and raises the price target from $34 to $42
Barclays maintains Organon OGN at Underweight and raises the price target from $7.5 to $8
Barclays maintains Oklo at Overweight and lowers the price target from $146 to $82
Oppenheimer maintains CarGurus CARG at Outperform and lowers the price target from $40 to $38
Barclays maintains Consolidated Edison at Underweight and raises the price target from $100 to $110
Barclays maintains Chesapeake Utilities CPK at Equal-Weight and lowers the price target from $141 to $140
Oppenheimer maintains Backblaze at Outperform and lowers the price target from $9.5 to $8.5
Cantor Fitzgerald maintains CrowdStrike Holdings CRWD at Overweight and lowers the price target from $590 to $520
Cantor Fitzgerald maintains Broadstone Net Lease at Overweight and raises the price target from $20 to $21
Oppenheimer maintains Allison Transmission ALSN at Outperform and raises the price target from $115 to $135
Chardan Capital upgrades Allurion Technologies ALUR from Neutral to Buy and raises the price target from $2.5 to $3
Keybanc maintains Welltower at Overweight and raises the price target from $210 to $240
Wedbush maintains Trade Desk at Neutral and lowers the price target from $40 to $23
Wedbush maintains Best Buy Co BBY at Neutral and lowers the price target from $80 to $70
Mizuho maintains Viper Energy at Outperform and raises the price target from $52 to $53
Mizuho maintains Quanta Services PWR at Neutral and raises the price target from $424 to $537
Wedbush maintains Paymentus Holdings at Outperform and lowers the price target from $40 to $32
Mizuho maintains Hershey HSY at Neutral and raises the price target from $165 to $195
Mizuho maintains Diamondback Energy at Outperform and raises the price target from $194 to $205
Scotiabank initiates coverage on Dakota Gold DC at Sector Outperform rating and announces a price target of $10
Citigroup downgrades GATX from Buy to Neutral and raises the price target from $197 to $210
Benchmark maintains Super Group SGHC at Buy and raises the price target from $17 to $18
Benchmark maintains Freshpet at Buy and raises the price target from $80 to $90
Morgan Stanley maintains Excelerate Energy EE at Equal-Weight and raises the price target from $30 to $40
Citigroup downgrades Arcellx ACLX from Buy to Neutral and raises the price target from $110 to $115
UBS downgrades Enhabit from Buy to Neutral and raises the price target from $12 to $13.8
RBC Capital initiates coverage on Carlyle Group CG at Outperform rating and announces a price target of $67
Oppenheimer maintains Dollar General at Outperform and raises the price target from $145 to $170
Seaport Global upgrades Fox FOXA from Neutral to Buy and announces a price target of $64
Stifel downgrades Arcellx from Buy to Hold and lowers the price target from $127 to $115
CIBC upgrades Equinox Gold EQX from Neutral to Outperformer and announces a price target of C$32
Stifel downgrades DT Midstream from Buy to Hold and raises the price target from $121 to $137
Wolfe Research initiates coverage on Xenon Pharmaceuticals XENE at Outperform rating and announces a price target of $60
Stifel initiates coverage on Gentherm at Buy rating and announces a price target of $41
Wolfe Research initiates coverage on Stoke Therapeutics STOK at Outperform rating and announces a price target of $40
Canaccord Genuity initiates coverage on Americas Gold And Silver at Buy rating and announces a price target of C$17
Wolfe Research initiates coverage on Definium Therapeutics DFTX at Outperform rating and announces a price target of $25
Morgan Stanley downgrades Cheniere Energy from Overweight to Equal-Weight and lowers the price target from $258 to $236
Morgan Stanley initiates coverage on Grindr GRND at Equal-Weight rating and announces a price target of $14
Morgan Stanley upgrades Freshpet FRPT from Equal-Weight to Overweight and raises the price target from $71 to $90
Mizuho downgrades Kilroy Realty KRC from Neutral to Underperform and lowers the price target from $37 to $29
Piper Sandler initiates coverage on Cactus at Overweight rating and announces a price target of $73
Needham maintains Ultra Clean Hldgs UCTT at Buy and raises the price target from $50 to $70
Deutsche Bank downgrades Blue Owl Capital OWL from Buy to Hold and lowers the price target from $15 to $10
BTIG maintains Zscaler at Buy and lowers the price target from $365 to $209
Deutsche Bank initiates coverage on Ethos Technologies LIFE at Buy rating and announces a price target of $23
B of A Securities downgrades Afya AFYA from Buy to Neutral and lowers the price target from $22 to $17
BTIG maintains Kratos Defense & Security at Buy and raises the price target from $95 to $115
Needham maintains Vir Biotechnology VIR at Buy and raises the price target from $14 to $18
BTIG maintains GeneDx Holdings at Buy and lowers the price target from $200 to $170
2-23-2026
UBS maintains Chemours CC at Buy and raises the price target from $18 to $23
UBS maintains Jones Lang LaSalle at Buy and raises the price target from $410 to $425
UBS maintains Marvell Technology MRVL at Buy and raises the price target from $115 to $120
UBS maintains HCA Healthcare HCA at Buy and raises the price target from $598 to $635
UBS maintains Autodesk at Buy and lowers the price target from $400 to $290
UBS maintains Bentley Systems BSY at Neutral and lowers the price target from $60 to $40
Citigroup maintains Republic Services at Buy and raises the price target from $244 to $253
Citigroup maintains PPL at Neutral and raises the price target from $36 to $38
Citigroup maintains TFI International at Buy and raises the price target from $131 to $143
Citigroup maintains Deere DE at Neutral and raises the price target from $515 to $675
Citigroup maintains Getty Images Holdings at Neutral and lowers the price target from $1.85 to $0.85
Citigroup maintains Telephone and Data Sys TDS at Buy and raises the price target from $51 to $56
Citigroup maintains Array Digital Infr at Buy and lowers the price target from $63 to $57
Jefferies maintains Nutrien NTR at Hold and raises the price target from $60 to $74
Jefferies maintains Wix.com at Buy and lowers the price target from $200 to $130
Jefferies maintains Asana ASAN at Hold and lowers the price target from $15 to $8
Jefferies maintains AAR at Buy and raises the price target from $112 to $135
Jefferies maintains GoDaddy GDDY at Hold and lowers the price target from $140 to $100
Jefferies maintains Adobe ADBE at Hold and lowers the price target from $400 to $290
Leerink Partners maintains Enhabit at Market Perform and raises the price target from $9.5 to $13.8
DA Davidson maintains Comfort Systems USA FIX at Buy and raises the price target from $1200 to $1800
DA Davidson maintains Deere at Buy and raises the price target from $580 to $775
DA Davidson maintains Louisiana-Pacific LPX at Buy and lowers the price target from $117 to $114
Jefferies initiates coverage on York Space Systems at Buy rating and announces a price target of $37
DA Davidson maintains Nordson NDSN at Buy and raises the price target from $290 to $335
Scotiabank maintains Devon Energy at Sector Perform and lowers the price target from $45 to $41
JP Morgan maintains Kinsale Cap KNSL at Neutral and lowers the price target from $450 to $410
JP Morgan maintains Copart at Neutral and lowers the price target from $45 to $34
Oppenheimer maintains WillScot Holdings WSC at Outperform and raises the price target from $24 to $25
Oppenheimer maintains Cogent Comms Hldgs at Outperform and lowers the price target from $40 to $30
Mizuho initiates coverage on Tango Therapeutics TNGX at Outperform rating and announces a price target of $19
JP Morgan maintains Toll Brothers at Overweight and raises the price target from $141 to $143
JP Morgan maintains TJX Companies TJX at Overweight and raises the price target from $154 to $173
Craig-Hallum initiates coverage on Amprius Technologies at Buy rating and announces a price target of $17
JP Morgan maintains Sensata Technologies ST at Underweight and raises the price target from $32 to $34
JP Morgan maintains Ross Stores at Overweight and raises the price target from $215 to $232
JP Morgan maintains Palomar Hldgs PLMR at Overweight and raises the price target from $155 to $160
JP Morgan maintains Kaiser Aluminum at Neutral and raises the price target from $118 to $124
JP Morgan maintains JM Smucker SJM at Overweight and raises the price target from $121 to $122
JP Morgan maintains ESAB at Overweight and raises the price target from $130 to $153
BMO Capital maintains Alliant Energy LNT at Outperform and raises the price target from $72 to $78
BMO Capital maintains Laureate Education at Outperform and raises the price target from $36 to $40
BMO Capital maintains TechnipFMC FTI at Market Perform and raises the price target from $52 to $67
Baird downgrades Arcellx ACLX from Outperform to Neutral and raises the price target from $106 to $115
Baird maintains RingCentral at Neutral and raises the price target from $30 to $34
Baird maintains Five9 FIVN at Neutral and lowers the price target from $24 to $19
Guggenheim maintains SentinelOne at Buy and lowers the price target from $28 to $24
B. Riley Securities maintains Nakamoto NAKA at Buy and lowers the price target from $1 to $0.5
Brookline Capital maintains C4 Therapeutics at Buy and raises the price target from $20 to $30
Cantor Fitzgerald maintains Remitly Global RELY at Overweight and raises the price target from $17 to $20
B. Riley Securities reiterates Nektar Therapeutics at Buy and raises the price target from $105 to $150
Cantor Fitzgerald maintains Global Payments GPN at Neutral and raises the price target from $80 to $88
Cantor Fitzgerald maintains Texas Instruments at Neutral and raises the price target from $225 to $250
B. Riley Securities maintains BitMine Immersion BMNR at Buy and lowers the price target from $47 to $30
Morgan Stanley maintains WillScot Holdings at Equal-Weight and raises the price target from $21 to $23
Morgan Stanley maintains Transocean RIG at Equal-Weight and raises the price target from $4.5 to $5
JP Morgan maintains Burlington Stores at Overweight and raises the price target from $316 to $356
Morgan Stanley maintains Tenaris TS at Underweight and raises the price target from $38 to $40
Barclays maintains Oceaneering International at Equal-Weight and raises the price target from $23 to $32
Morgan Stanley maintains Snap SNAP at Equal-Weight and lowers the price target from $9.5 to $6.5
Morgan Stanley maintains PTC Therapeutics at Overweight and raises the price target from $90 to $92
Morgan Stanley maintains Lumentum Holdings LITE at Equal-Weight and raises the price target from $420 to $520
Barclays maintains Iron Mountain at Overweight and raises the price target from $123 to $127
Morgan Stanley maintains Life Time Group Hldgs LTH at Overweight and raises the price target from $37 to $38
Morgan Stanley maintains Corning at Equal-Weight and raises the price target from $103 to $127
Barclays maintains Expro Hldgs XPRO at Overweight and raises the price target from $16 to $21
Barclays maintains EQT at Overweight and raises the price target from $64 to $67
Morgan Stanley maintains Ciena at Equal-Weight and raises the price target from $213 to $280
Barclays maintains Devon Energy DVN at Overweight and raises the price target from $50 to $52
Morgan Stanley maintains Chemours at Equal-Weight and raises the price target from $15 to $17
Barclays maintains CMS Energy CMS at Overweight and raises the price target from $74 to $79
Stifel maintains Dnow at Buy and lowers the price target from $18 to $16
Evercore ISI Group maintains Walmart WMT at Outperform and raises the price target from $130 to $135
Jefferies downgrades Docusign from Buy to Hold and lowers the price target from $105 to $45
RBC Capital maintains Nutrien NTR at Outperform and raises the price target from $75 to $80
RBC Capital maintains Gaming and Leisure Props at Outperform and raises the price target from $53 to $54
Evercore ISI Group maintains Timken TKR at Outperform and raises the price target from $86 to $129
Evercore ISI Group maintains Terex at Outperform and raises the price target from $64 to $82
RBC Capital maintains Celanese CE at Sector Perform and raises the price target from $48 to $55
Evercore ISI Group maintains PACCAR at Outperform and raises the price target from $119 to $143
Evercore ISI Group maintains Oshkosh OSK at Outperform and raises the price target from $148 to $202
Evercore ISI Group maintains Monster Beverage at Outperform and raises the price target from $80 to $85
UBS upgrades BlackRock BLK from Neutral to Buy and maintains the price target at $1280
Evercore ISI Group maintains Illinois Tool Works at Underperform and raises the price target from $253 to $296
Evercore ISI Group maintains Ingersoll Rand IR at In-Line and raises the price target from $82 to $94
Evercore ISI Group maintains Gates Industrial Corp at In-Line and raises the price target from $24 to $30
Evercore ISI Group maintains TechnipFMC FTI at Outperform and raises the price target from $48 to $71
RBC Capital maintains Lowe’s Companies LOW at Sector Perform and raises the price target from $252 to $257
Evercore ISI Group maintains Extra Space Storage at In-Line and raises the price target from $147 to $150
Evercore ISI Group maintains Deere DE at In-Line and raises the price target from $458 to $641
UBS upgrades CBRE Group from Neutral to Buy and raises the price target from $175 to $185
Evercore ISI Group maintains CNH Industrial CNH at In-Line and raises the price target from $11 to $13
Evercore ISI Group maintains Cummins at Outperform and raises the price target from $576 to $694
Evercore ISI Group maintains Caterpillar CAT at Outperform and raises the price target from $630 to $878
Keefe, Bruyette & Woods maintains Blue Owl Technology at Market Perform and lowers the price target from $16 to $13
Benchmark maintains Teck Resources TECK at Buy and raises the price target from $48 to $67
Susquehanna maintains STMicroelectronics at Positive and raises the price target from $35 to $40
Susquehanna maintains Valaris at Neutral and raises the price target from $87 to $96
Susquehanna maintains Transocean RIG at Positive and raises the price target from $6.5 to $7.5
Citizens maintains AMN Healthcare Services at Market Outperform and raises the price target from $22 to $24
Susquehanna maintains Oil States International OIS at Neutral and raises the price target from $8 to $13
Truist Securities maintains AdvanSix at Hold and raises the price target from $19 to $20
Truist Securities reiterates Tandem Diabetes Care TNDM at Hold and raises the price target from $24 to $27
Truist Securities maintains Cava Group at Buy and raises the price target from $78 to $80
JP Morgan downgrades VF VFC from Neutral to Underweight and lowers the price target from $19 to $18
JP Morgan downgrades Mister Car Wash MCW from Overweight to Neutral and lowers the price target from $8 to $7
Wedbush reiterates Pure Storage at Outperform and maintains the price target at $100
Piper Sandler maintains Akamai Technologies AKAM at Neutral and raises the price target from $89 to $97
Wedbush reiterates Imax at Outperform and maintains the price target at $46
BTIG reiterates Etsy ETSY at Buy and maintains a price target of $65
BTIG maintains Snowflake at Buy and lowers the price target from $312 to $235
Piper Sandler maintains TWFG TWFG at Overweight and lowers the price target from $32 to $22
Piper Sandler maintains Accelerant Holdings at Overweight and lowers the price target from $18 to $13
TD Cowen reiterates Domino’s Pizza DPZ at Hold and maintains the price target at $460
Piper Sandler maintains Target at Neutral and raises the price target from $85 to $102
Piper Sandler maintains Home Depot HD at Overweight and lowers the price target from $441 to $422
Piper Sandler maintains Best Buy Co at Neutral and lowers the price target from $76 to $71
Piper Sandler maintains RingCentral RNG at Neutral and raises the price target from $28 to $37
Piper Sandler maintains Bristol-Myers Squibb at Overweight and raises the price target from $66 to $75
B of A Securities initiates coverage on Ethos Technologies LIFE at Buy rating and announces a price target of $15
Mizuho upgrades ACADIA Pharmaceuticals from Neutral to Outperform and raises the price target from $29 to $35
Keybanc upgrades Macerich MAC from Sector Weight to Overweight and announces a price target of $25
Goldman Sachs initiates coverage on York Space Systems at Neutral rating and announces a price target of $29
Citizens initiates coverage on MiMedx Group MDXG at Market Outperform rating and announces a price target of $10
Baird upgrades Henry Schein HSIC from Neutral to Outperform and raises the price target from $78 to $100
Goldman Sachs initiates coverage on Ethos Technologies at Buy rating and announces a price target of $33
Ascendiant Capital maintains IGC Pharma IGC at Buy and raises the price target from $4.75 to $5
Baird initiates coverage on York Space Systems at Outperform rating and announces a price target of $40